<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37762599</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>29</Day></DateCompleted><DateRevised><Year>2023</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>18</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>19</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">14296</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241814296</ELocationID><Abstract><AbstractText>Neurodegenerative disorders (NDDs) are complex, multifactorial disorders with significant social and economic impact in today's society. NDDs are predicted to become the second-most common cause of death in the next few decades due to an increase in life expectancy but also to a lack of early diagnosis and mainly symptomatic treatment. Despite recent advances in diagnostic and therapeutic methods, there are yet no reliable biomarkers identifying the complex pathways contributing to these pathologies. The development of new approaches for early diagnosis and new therapies, together with the identification of non-invasive and more cost-effective diagnostic biomarkers, is one of the main trends in NDD biomedical research. Here we summarize data on peripheral biomarkers, biofluids (cerebrospinal fluid and blood plasma), and peripheral blood cells (platelets (PLTs) and red blood cells (RBCs)), reported so far for the three most common NDDs-Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). PLTs and RBCs, beyond their primary physiological functions, are increasingly recognized as valuable sources of biomarkers for NDDs. Special attention is given to the morphological and nanomechanical signatures of PLTs and RBCs as biophysical markers for the three pathologies. Modifications of the surface nanostructure and morphometric and nanomechanical signatures of PLTs and RBCs from patients with AD, PD, and ALS have been revealed by atomic force microscopy (AFM). AFM is currently experiencing rapid and widespread adoption in biomedicine and clinical medicine, in particular for early diagnostics of various medical conditions. AFM is a unique instrument without an analog, allowing the generation of three-dimensional cell images with extremely high spatial resolution at near-atomic scale, which are complemented by insights into the mechanical properties of cells and subcellular structures. Data demonstrate that AFM can distinguish between the three pathologies and the normal, healthy state. The specific PLT and RBC signatures can serve as biomarkers in combination with the currently used diagnostic tools. We highlight the strong correlation of the morphological and nanomechanical signatures between RBCs and PLTs in PD, ALS, and AD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Taneva</LastName><ForeName>Stefka G</ForeName><Initials>SG</Initials><AffiliationInfo><Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, "Acad. G. Bontchev" Str. 21, 1113 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Todinova</LastName><ForeName>Svetla</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7108-051X</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, "Acad. G. Bontchev" Str. 21, 1113 Sofia, Bulgaria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Andreeva</LastName><ForeName>Tonya</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0003-4062-6043</Identifier><AffiliationInfo><Affiliation>Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, "Acad. G. Bontchev" Str. 21, 1113 Sofia, Bulgaria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Life Sciences, Reutlingen University, Alteburgstra&#xdf;e 150, D-72762 Reutlingen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>KP-06-H31/8</GrantID><Agency>Bulgarian Science Fund</Agency><Country/></Grant><Grant><GrantID>funding programme Open Access Publishing</GrantID><Agency>Baden-W&#xfc;rttemberg Ministry of Science, Research and Culture</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010300" MajorTopicYN="Y">Parkinson Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000544" MajorTopicYN="Y">Alzheimer Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018625" MajorTopicYN="N">Microscopy, Atomic Force</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001773" MajorTopicYN="N">Blood Cells</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">atomic force microscopy</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">cell morphology</Keyword><Keyword MajorTopicYN="N">cell nanomechanics</Keyword><Keyword MajorTopicYN="N">neurodegenerative disorders</Keyword><Keyword MajorTopicYN="N">platelets</Keyword><Keyword MajorTopicYN="N">red blood cells</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>9</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37762599</ArticleId><ArticleId IdType="pmc">PMC10531602</ArticleId><ArticleId IdType="doi">10.3390/ijms241814296</ArticleId><ArticleId IdType="pii">ijms241814296</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hou Y., Dan X., Babbar M., Wei Y., Hasselbalch S.G., Croteau D.L., Bohr V.A. Ageing as a risk factor for neurodegenerative disease. Nat. Rev. Neurol. 2019;15:565&#x2013;581. doi: 10.1038/s41582-019-0244-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0244-7</ArticleId><ArticleId IdType="pubmed">31501588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciccone S., Maiani E., Bellusci G., Diederich M., Gonfloni S. Parkinson&#x2019;s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress. Int. J. Mol. Sci. 2013;14:2388&#x2013;2409. doi: 10.3390/ijms14022388.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms14022388</ArticleId><ArticleId IdType="pmc">PMC3587993</ArticleId><ArticleId IdType="pubmed">23348931</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Chen M., Jiang J. Mitochondrial dysfunction in neurodegenerative diseases and drug targets via apoptotic signaling. Mitochondrion. 2019;49:35&#x2013;45. doi: 10.1016/j.mito.2019.07.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mito.2019.07.003</ArticleId><ArticleId IdType="pubmed">31288090</ArticleId></ArticleIdList></Reference><Reference><Citation>Profaci C.P., Munji R.N., Pulido R.S., Daneman R. The blood&#x2013;brain barrier in health and disease: Important unanswered questions. J. Exp. Med. 2020;217:e20190062. doi: 10.1084/jem.20190062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20190062</ArticleId><ArticleId IdType="pmc">PMC7144528</ArticleId><ArticleId IdType="pubmed">32211826</ArticleId></ArticleIdList></Reference><Reference><Citation>Younes-Mhenni S., Frih-Ayed M., Kerkeni A., Bost M., Chazot G. Peripheral blood markers of oxidative stress in Parkinson&#x2019;s disease. Eur. Neurol. 2007;58:78&#x2013;83. doi: 10.1159/000103641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000103641</ArticleId><ArticleId IdType="pubmed">17565220</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A., Kukreti R., Saso L., Kukreti S. Oxidative Stress: A Key Modulator in Neurodegenerative Diseases. Molecules. 2019;24:1583. doi: 10.3390/molecules24081583.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24081583</ArticleId><ArticleId IdType="pmc">PMC6514564</ArticleId><ArticleId IdType="pubmed">31013638</ArticleId></ArticleIdList></Reference><Reference><Citation>Jenner P., Olanow C.W. Oxidative stress and the pathogenesis of Parkinson&#x2019;s disease. Neurology. 1996;47:161&#x2013;170. doi: 10.1212/WNL.47.6_Suppl_3.161S.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.47.6_Suppl_3.161S</ArticleId><ArticleId IdType="pubmed">8959985</ArticleId></ArticleIdList></Reference><Reference><Citation>Betzer C., Jensen P.H. Reduced Cytosolic Calcium as an Early Decisive Cellular State in Parkinson&#x2019;s Disease and Synucleinopathies. Front. Neurosci. 2018;12:819. doi: 10.3389/fnins.2018.00819.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2018.00819</ArticleId><ArticleId IdType="pmc">PMC6232531</ArticleId><ArticleId IdType="pubmed">30459551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Zheng W. Ca2+ homeostasis dysregulation in Alzheimer&#x2019;s disease: A focus on plasma membrane and cell organelles. FASEB J. 2019;33:6697&#x2013;6712. doi: 10.1096/fj.201801751R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801751R</ArticleId><ArticleId IdType="pubmed">30848934</ArticleId></ArticleIdList></Reference><Reference><Citation>Meszl&#xe9;nyi V., Patai R., Polg&#xe1;r T.F., N&#xf3;gr&#xe1;di B., K&#xf6;rm&#xf6;czy L., Krist&#xf3;f R., Spis&#xe1;k K., Tripolszki K., Sz&#xe9;ll M., Ob&#xe1;l I., et al. Passive Transfer of Sera from ALS Patients with Identified Mutations Evokes an Increased Synaptic Vesicle Number and Elevation of Calcium Levels in Motor Axon Terminals, Similar to Sera from Sporadic Patients. Int. J. Mol. Sci. 2020;21:5566. doi: 10.3390/ijms21155566.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21155566</ArticleId><ArticleId IdType="pmc">PMC7432249</ArticleId><ArticleId IdType="pubmed">32756522</ArticleId></ArticleIdList></Reference><Reference><Citation>Piscopo P., Bellenghi M., Manzini V., Crestini A., Pontecorvi G., Corbo M., Ortona E., Car&#xe8; A., Confaloni A. A Sex Perspective in Neurodegenerative Diseases: MicroRNAs as Possible Peripheral Biomarkers. Int. J. Mol. Sci. 2021;22:4423. doi: 10.3390/ijms22094423.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22094423</ArticleId><ArticleId IdType="pmc">PMC8122918</ArticleId><ArticleId IdType="pubmed">33922607</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M. NEURODEGENERATION. Alzheimer&#x2019;s and Parkinson&#x2019;s diseases: The prion concept in relation to assembled A&#x3b2;, tau, and &#x3b1;-synuclein. Science. 2015;349:1255555. doi: 10.1126/science.1255555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1255555</ArticleId><ArticleId IdType="pubmed">26250687</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinker K.A. Basic mechanisms of neurodegeneration: Acritical update. J. Cell Mol. Med. 2010;14:457&#x2013;487. doi: 10.1111/j.1582-4934.2010.01010.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1582-4934.2010.01010.x</ArticleId><ArticleId IdType="pmc">PMC3823450</ArticleId><ArticleId IdType="pubmed">20070435</ArticleId></ArticleIdList></Reference><Reference><Citation>Amor S., Peferoen L.A.N., Vogel D.Y.S., Breur M., van der Valk P., Baker D., van Noort J.M. Inflammation in neurodegenerative diseases&#x2014;An update. Immunology. 2014;142:151&#x2013;166. doi: 10.1111/imm.12233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12233</ArticleId><ArticleId IdType="pmc">PMC4008224</ArticleId><ArticleId IdType="pubmed">24329535</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee S. Oxidative Stress, Inflammation, and Disease. In: Dziubla T., Butterfield D.A., editors. Oxidative stress and Biomaterials. Elsevier Inc./Academic Press; Cambridge, MA, USA: 2016. pp. 35&#x2013;58.</Citation></Reference><Reference><Citation>Migliore L., Copped&#xe8; F. Environmental-induced oxidative stress in neurodegenerative disorders and aging. Mutat. Genet. Toxicol. Environ. Mutagen. 2009;674:73&#x2013;84. doi: 10.1016/j.mrgentox.2008.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mrgentox.2008.09.013</ArticleId><ArticleId IdType="pubmed">18952194</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson T.B., Chaggar P., Kuhl E., Goriely A. Protein-protein interactions in neurodegenerative diseases: A conspiracy theory. PLoS Comput. Biol. 2020;16:e1008267. doi: 10.1371/journal.pcbi.1008267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1008267</ArticleId><ArticleId IdType="pmc">PMC7584458</ArticleId><ArticleId IdType="pubmed">33048932</ArticleId></ArticleIdList></Reference><Reference><Citation>Giacomelli C., Daniele S., Martini C. Potential biomarkers and novel pharmacological targets in protein aggregation-related neurodegenerative diseases. Biochem. Pharmacol. 2017;131:1&#x2013;15. doi: 10.1016/j.bcp.2017.01.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2017.01.017</ArticleId><ArticleId IdType="pubmed">28159621</ArticleId></ArticleIdList></Reference><Reference><Citation>Meldolesi J. News about the Role of Fluid and Imaging Biomarkers in Neurodegenerative Diseases. Biomedicines. 2021;9:252. doi: 10.3390/biomedicines9030252.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines9030252</ArticleId><ArticleId IdType="pmc">PMC7999537</ArticleId><ArticleId IdType="pubmed">33806691</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojsiat J., Prandelli C., Laskowska-Kaszub K., Mart&#xed;n-Requero A., Wojda U. Oxidative Stress and Aberrant Cell Cycle in Alzheimer&#x2019;s Disease Lymphocytes: Diagnostic Prospects. J. Alzheimer&#x2019;s Dis. 2015;46:329&#x2013;350. doi: 10.3233/JAD-141977.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141977</ArticleId><ArticleId IdType="pubmed">25737047</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertolotti A. Importance of the subcellular location of protein deposits in neurodegenerative diseases. Curr. Opin. Neurobiol. 2018;51:127&#x2013;133. doi: 10.1016/j.conb.2018.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2018.03.004</ArticleId><ArticleId IdType="pubmed">29631171</ArticleId></ArticleIdList></Reference><Reference><Citation>Cuanalo-Contreras K., Mukherjee A., Soto C. Role of protein misfolding and proteostasis deficiency in protein misfolding diseases and aging. Int. J. Cell Biol. 2013;2013:638083. doi: 10.1155/2013/638083.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/638083</ArticleId><ArticleId IdType="pmc">PMC3855986</ArticleId><ArticleId IdType="pubmed">24348562</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikis E.A., Gidalevitz T., Morimoto R.I. Protein homeostasis in models of aging and age-related conformational disease. Adv. Exp. Med. Biol. 2010;694:138&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402352</ArticleId><ArticleId IdType="pubmed">20886762</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Pritzkow S. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 2018;4:49&#x2013;60. doi: 10.1038/nrn1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1007</ArticleId><ArticleId IdType="pubmed">12511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Baldacci F., Daniele S., Piccarducci R., Giampietri L., Pietrobono D., Giorgi F.S., Nicoletti V., Frosini D., Libertini P., Lo Gerfo A., et al. Potential Diagnostic Value of Red Blood Cells &#x3b1;-Synuclein Heteroaggregates in Alzheimer&#x2019;s Disease. Mol. Neurobiol. 2019;56:6451&#x2013;6459. doi: 10.1007/s12035-019-1531-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-019-1531-4</ArticleId><ArticleId IdType="pubmed">30826968</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiko T., Nakagawa K., Satoh A., Tsuduki T., Furukawa K., Arai H., Miyazawa T. Amyloid &#x3b2; levels in human red blood cells. PLoS ONE. 2012;7:e49620. doi: 10.1371/journal.pone.0049620.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0049620</ArticleId><ArticleId IdType="pmc">PMC3499416</ArticleId><ArticleId IdType="pubmed">23166730</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersen A.D., Binzer M., Stenager E., Gramsbergen J.B. Cerebrospinal fluid biomarkers for Parkinson&#x2019;s disease: A systematic review. Acta Neurol. Scand. 2017;135:34&#x2013;56. doi: 10.1111/ane.12590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.12590</ArticleId><ArticleId IdType="pubmed">26991855</ArticleId></ArticleIdList></Reference><Reference><Citation>Beach T.G. A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley? Neurol. Ther. 2017;6:5&#x2013;13. doi: 10.1007/s40120-017-0072-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40120-017-0072-x</ArticleId><ArticleId IdType="pmc">PMC5520818</ArticleId><ArticleId IdType="pubmed">28733961</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C., van Wieringen W.N., Zetterberg H., Tijms B.M., Teunissen C.E., The NFL Group Diagnostic value of cerebrospinalfluid neurofilament light protein in neurology: A systematic review and meta-analysis. JAMA Neurol. 2019;76:1035&#x2013;1048. doi: 10.1001/jamaneurol.2019.1534.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2019.1534</ArticleId><ArticleId IdType="pmc">PMC6580449</ArticleId><ArticleId IdType="pubmed">31206160</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B., Lautner R., Andreasson U., &#xd6;hrfelt A., Portelius E., Bjerke M., H&#xf6;ltt&#xe4; M., Ros&#xe9;n C. CSF and blood biomarkers for the diagnosis of Alzheimer&#x2019;s disease: A systematic review and meta-analysis. Lancet Neurol. 2016;15:673&#x2013;684. doi: 10.1016/S1474-4422(16)00070-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(16)00070-3</ArticleId><ArticleId IdType="pubmed">27068280</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura A., Kaneko N., Villemagne V.L., Kato T., Doecke J., Dor&#xe9; V., Fowler C., Li Q.-X., Martins R., Rowe C., et al. High performance plasma amyloid-&#x3b2; biomarkers for Alzheimer&#x2019;s disease. Nature. 2018;554:249&#x2013;254. doi: 10.1038/nature25456.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature25456</ArticleId><ArticleId IdType="pubmed">29420472</ArticleId></ArticleIdList></Reference><Reference><Citation>Seelaar H., Van Swieten J.C. In vivo PET imaging of neuroinflammation in familial frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry. 2021;92:319&#x2013;322. doi: 10.1136/jnnp-2020-324348.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-324348</ArticleId><ArticleId IdType="pmc">PMC7892378</ArticleId><ArticleId IdType="pubmed">33122395</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson O. Biomarkers for neurodegenerative diseases. Nat. Med. 2021;27:954&#x2013;963. doi: 10.1038/s41591-021-01382-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01382-x</ArticleId><ArticleId IdType="pubmed">34083813</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;mez-R&#xed;o M., Caballero M.M., G&#xf3;rriz S&#xe1;ez J.M., M&#xed;nguez-Castellanos A. Diagnosis of Neurodegenerative Diseases: The Clinical Approach. Curr. Alzheimer Res. 2016;13:469&#x2013;474. doi: 10.2174/1567205013666151116141603.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205013666151116141603</ArticleId><ArticleId IdType="pubmed">26567736</ArticleId></ArticleIdList></Reference><Reference><Citation>Shusharina N., Yukhnenko D., Botman S., Sapunov V., Savinov V., Kamyshov G., Sayapin D., Voznyuk I. Modern Methods of Diagnostics and Treatment of Neurodegenerative Diseases and Depression. Diagnostics. 2023;13:573. doi: 10.3390/diagnostics13030573.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13030573</ArticleId><ArticleId IdType="pmc">PMC9914271</ArticleId><ArticleId IdType="pubmed">36766678</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Jr., Petersen R.C., Xu Y.C., O&#x2019;Brien P.C., Smith G.E., Ivnik R.J., Boeve B.F., Waring S.C., Tangalos E.G., Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52:1397&#x2013;1403. doi: 10.1212/WNL.52.7.1397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.52.7.1397</ArticleId><ArticleId IdType="pmc">PMC2730146</ArticleId><ArticleId IdType="pubmed">10227624</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamagata K., Andica C., Kato A., Saito Y., Uchida W., Hatano T., Lukies M., Ogawa T., Takeshige-Amano H., Akashi T., et al. Diffusion Magnetic Resonance Imaging-Based Biomarkers for Neurodegenerative Diseases. Int. J. Mol. Sci. 2021;22:5216. doi: 10.3390/ijms22105216.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22105216</ArticleId><ArticleId IdType="pmc">PMC8155849</ArticleId><ArticleId IdType="pubmed">34069159</ArticleId></ArticleIdList></Reference><Reference><Citation>Assaf Y., Pasternak O. Diffusion Tensor Imaging (DTI)-based White Matter Mapping in Brain Research: A Review. J. Mol. Neurosci. 2008;34:51&#x2013;61. doi: 10.1007/s12031-007-0029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-007-0029-0</ArticleId><ArticleId IdType="pubmed">18157658</ArticleId></ArticleIdList></Reference><Reference><Citation>Choo X.Y., Alukaidey L., White A.R., Grubman A. Neuroinflammation and Copper in Alzheimer&#x2019;s Disease. Int. J. Alzheimer&#x2019;s Dis. 2013;2013:145345. doi: 10.1155/2013/145345.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/145345</ArticleId><ArticleId IdType="pmc">PMC3863554</ArticleId><ArticleId IdType="pubmed">24369524</ArticleId></ArticleIdList></Reference><Reference><Citation>Grimmer T., Wutz C., Alexopoulos P., Drzezga A., F&#xf6;rster S., F&#xf6;rstl H., Goldhardt O., Ortner M., Sorg C., Kurz A. Visual Versus Fully Automated Analyses of &#x3b2;-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. J. Nucl. Med. 2016;57:204&#x2013;207. doi: 10.2967/jnumed.115.163717.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.115.163717</ArticleId><ArticleId IdType="pubmed">26585056</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowley P.A., Samsonov A.A., Betthauser T.J., Pirasteh A., Johnson S.C., Eisenmenger L.B. Amyloid and Tau PET Imaging of Alzheimer Disease and Other Neurodegenerative Conditions. Semin. Ultrasound CT MRI. 2020;41:572&#x2013;583. doi: 10.1053/j.sult.2020.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.sult.2020.08.011</ArticleId><ArticleId IdType="pubmed">33308496</ArticleId></ArticleIdList></Reference><Reference><Citation>Knopman D.S., Jagust J.W. Alzheimer Disease Spectrum: Syndrome and Etiology from Clinical and PET Imaging Perspectives. Neurology. 2021;96:7. doi: 10.1212/WNL.0000000000011415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011415</ArticleId><ArticleId IdType="pmc">PMC8570920</ArticleId><ArticleId IdType="pubmed">33361254</ArticleId></ArticleIdList></Reference><Reference><Citation>Saeed U., Compagnone J., Aviv R.I., Strafella A.P., Black S.E., Lang A.E., Masellis M. Imaging biomarkers in Parkinson&#x2019;s disease and Parkinsonian syndromes: Current and emerging concepts. Transl. Neurodegener. 2017;6:8. doi: 10.1186/s40035-017-0076-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-017-0076-6</ArticleId><ArticleId IdType="pmc">PMC5370489</ArticleId><ArticleId IdType="pubmed">28360997</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Jr., Wiste H.J., Algeciras-Schimnich A., Figdore D.J., Schwarz C.G., Lowe V.J., Ramanan V.K., Vemuri P., Mielke M.M., Knopman D.S., et al. Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain. 2023;146:2029&#x2013;2044. doi: 10.1093/brain/awad042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awad042</ArticleId><ArticleId IdType="pmc">PMC10151195</ArticleId><ArticleId IdType="pubmed">36789483</ArticleId></ArticleIdList></Reference><Reference><Citation>Cova I., Priori A. Diagnostic biomarkers for Parkinson&#x2019;s disease at a glance: Where are we? J. Neural. Transm. 2018;125:1417&#x2013;1432. doi: 10.1007/s00702-018-1910-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-018-1910-4</ArticleId><ArticleId IdType="pmc">PMC6132920</ArticleId><ArticleId IdType="pubmed">30145631</ArticleId></ArticleIdList></Reference><Reference><Citation>He R., Yan X., Guo J., Xu Q., Tang B., Sun Q. Recent advances in biomarkers for Parkinson&#x2019;s disease. Front. Aging Neurosci. 2018;10:305. doi: 10.3389/fnagi.2018.00305.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2018.00305</ArticleId><ArticleId IdType="pmc">PMC6193101</ArticleId><ArticleId IdType="pubmed">30364199</ArticleId></ArticleIdList></Reference><Reference><Citation>Laterza O.F., Hendrickson R.C., Wagner J.A. Molecular Biomarkers. Ther. Innov. Regul. Sci. 2007;41:573&#x2013;585. doi: 10.1177/009286150704100504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/009286150704100504</ArticleId></ArticleIdList></Reference><Reference><Citation>Broza Y.Y., Zhou X., Yuan M., Qu D., Zheng Y., Vishinkin R., Khatib M., Wu W., Haick H. Disease Detection with Molecular Biomarkers: From Chemistry of Body Fluids to Nature-Inspired Chemical Sensors. Chem. Rev. 2019;119:11761&#x2013;11817. doi: 10.1021/acs.chemrev.9b00437.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.9b00437</ArticleId><ArticleId IdType="pubmed">31729868</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K., Hampel H., Weiner M., Zetterberg H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 2010;6:131&#x2013;144. doi: 10.1038/nrneurol.2010.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2010.4</ArticleId><ArticleId IdType="pubmed">20157306</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewczuk P., Riederer P., O&#x2019;Bryant S.E., Verbeek M.M., Dubois B., Visser P.J., Jellinger K.A., Engelborghs S., Ramirez A., Parnetti L., et al. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J. Biol. Psychiatry. 2018;19:244&#x2013;328. doi: 10.1080/15622975.2017.1375556.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15622975.2017.1375556</ArticleId><ArticleId IdType="pmc">PMC5916324</ArticleId><ArticleId IdType="pubmed">29076399</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K., Zetterberg H. The past and future of Alzheimer&#x2019;s disease fluid biomarkers. J. Alzhimer&#x2019;s Dis. 2018;62:1125&#x2013;1140. doi: 10.3233/JAD-170773.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170773</ArticleId><ArticleId IdType="pmc">PMC5869995</ArticleId><ArticleId IdType="pubmed">29562534</ArticleId></ArticleIdList></Reference><Reference><Citation>Wojsiat J., Laskowska-Kaszub K., Mietelska-Porowska A., Wojda U. Search for Alzheimer&#x2019;s disease biomarkers in blood cells: Hypotheses-driven approach. Biomark. Med. 2017;11:917&#x2013;931. doi: 10.2217/bmm-2017-0041.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/bmm-2017-0041</ArticleId><ArticleId IdType="pubmed">28976776</ArticleId></ArticleIdList></Reference><Reference><Citation>Posavi M., Diaz-Ortiz M., Liu B., Swanson C.R., Skrinak R.T., Hernandez-Con P., Amado D.A., Fullard M., Rick J., Siderowf A., et al. Characterization of Parkinson&#x2019;s disease using blood-based biomarkers: A multicohort proteomic analysis. PLoS Med. 2019;16:e1002931. doi: 10.1371/journal.pmed.1002931.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1002931</ArticleId><ArticleId IdType="pmc">PMC6788685</ArticleId><ArticleId IdType="pubmed">31603904</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton N.J., Hye A., Rajkumar A.P., Leuzy A., Snowden S., Su&#xe1;rez-Calvet M., Karikari T.K., Sch&#xf6;ll M., La Joie R., Rabinovici G.D., et al. An update on blood-based biomarkers for non-Alzheimer neurodegenerative disorders. Nat. Rev. Neurol. 2020;16:265&#x2013;284. doi: 10.1038/s41582-020-0348-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-020-0348-0</ArticleId><ArticleId IdType="pubmed">32322100</ArticleId></ArticleIdList></Reference><Reference><Citation>Langbaum J.B., Fleisher A.S., Chen K., Ayutyanont N., Lopera F., Quiroz Y.T., Caselli R.J., Tariot P.N., Reiman E.M. Ushering in the study and treatment of preclinical Alzheimer disease. Nat. Rev. Neurol. 2013;9:371&#x2013;381. doi: 10.1038/nrneurol.2013.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2013.107</ArticleId><ArticleId IdType="pmc">PMC4084675</ArticleId><ArticleId IdType="pubmed">23752908</ArticleId></ArticleIdList></Reference><Reference><Citation>Schapira A.H. Recent developments in biomarkers in Parkinson disease. Curr. Opin. Neurol. 2013;26:395&#x2013;400. doi: 10.1097/WCO.0b013e3283633741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e3283633741</ArticleId><ArticleId IdType="pmc">PMC4196782</ArticleId><ArticleId IdType="pubmed">23823465</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee P.H., Lee G., Park H.J., Bang O.Y., Joo I.S., Huh K. The plasma &#x3b1;-synuclein levels in patients with Parkinson&#x2019;s disease and multiple system atrophy. J. Neural Transm. 2006;113:1435&#x2013;1439. doi: 10.1007/s00702-005-0427-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-005-0427-9</ArticleId><ArticleId IdType="pubmed">16465458</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Q.X., Mok S.S., Laughton K.M., McLean C.A., Cappai R., Masters C.L., Culvenor J.G., Horne M.K. Plasma &#x3b1;-synuclein is decreased in subjects with Parkinson&#x2019;s disease. Exp. Neurol. 2007;204:583&#x2013;588. doi: 10.1016/j.expneurol.2006.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2006.12.006</ArticleId><ArticleId IdType="pubmed">17258710</ArticleId></ArticleIdList></Reference><Reference><Citation>Hong Z., Shi M., Chung K.A., Quinn J.F., Peskind E.R., Galasko D., Jankovic J., Zabetian C.P., Leverenz J.B., Baird G., et al. DJ-1 and &#x3b1;-synuclein in human cerebrospinal fluid as biomarkers of Parkinson&#x2019;s disease. Brain. 2010;133:713&#x2013;726. doi: 10.1093/brain/awq008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awq008</ArticleId><ArticleId IdType="pmc">PMC2842513</ArticleId><ArticleId IdType="pubmed">20157014</ArticleId></ArticleIdList></Reference><Reference><Citation>Mollenhauer B., Locascio J.L., Schulz-Schaeffer W., Sixel-D&#xf6;ring F., Trenkwalder C., Schlossmacher M.G. &#x3b1;-synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: A cohort study. Lancet Neurol. 2011;10:230&#x2013;240. doi: 10.1016/S1474-4422(11)70014-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(11)70014-X</ArticleId><ArticleId IdType="pubmed">21317042</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin C.-H., Yang S.-Y., Horng H.-E., Yang C.-C., Chieh J.-J., Chen H.-H., Liu B.-H., Chiu M.-J. Plasma &#x3b1;-synuclein predicts cognitive decline in Parkinson&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2017;88:818&#x2013;824. doi: 10.1136/jnnp-2016-314857.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2016-314857</ArticleId><ArticleId IdType="pmc">PMC5629933</ArticleId><ArticleId IdType="pubmed">28550072</ArticleId></ArticleIdList></Reference><Reference><Citation>Polimeno L., Asabella A.N., Mazzocca A., De Fazio G., Polimeno R., Buquicchio R., Lavelli V., Rubini G. Plasma levels of clusterin are representative of the early phase of the neurodegenerative process in Parkinson&#x2019;s disease. J. Clin. Mol. Med. 2018;1:1&#x2013;5. doi: 10.15761/JCMM.1000102.</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/JCMM.1000102</ArticleId></ArticleIdList></Reference><Reference><Citation>Chio A., Calvo A., Bovio G., Canosa A., Bertuzzo D., Galmozzi F., Cugnasco P., Clerico M., De Mercanti S., Bersano E., et al. Amyotrophic lateral sclerosis outcome measures and the role of albumin and creatinine. JAMA Neurol. 2014;71:1134&#x2013;1142. doi: 10.1001/jamaneurol.2014.1129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2014.1129</ArticleId><ArticleId IdType="pubmed">25048026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryberg H., Bowser R. Protein biomarkers for amyotrophic lateral sclerosis. Expert Rev. Proteom. 2008;5:249&#x2013;262. doi: 10.1586/14789450.5.2.249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/14789450.5.2.249</ArticleId><ArticleId IdType="pubmed">18466055</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner M.R., Kiernan M.C., Leigh P.N., Talbot K. Biomarkers in amyotrophic lateral sclerosis. Lancet Neurol. 2009;8:94&#x2013;109. doi: 10.1016/S1474-4422(08)70293-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70293-X</ArticleId><ArticleId IdType="pubmed">19081518</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn J.F., Patel T., Wong D., Das S., Freedman J.E., Laurent L.C., Carter B.S., Hochberg F., Van Keuren-Jensen K., Huentelman M., et al. Extracellular RNAs: Development as biomarkers of human disease. J. Extracell. Vesicles. 2015;4:27495. doi: 10.3402/jev.v4.27495.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/jev.v4.27495</ArticleId><ArticleId IdType="pmc">PMC4553262</ArticleId><ArticleId IdType="pubmed">26320940</ArticleId></ArticleIdList></Reference><Reference><Citation>Blennow K., Zetterberg H. Biomarkers for Alzheimer&#x2019;s Disease: Current Status and Prospects for the Future. J. Intern. Med. 2018;284:643&#x2013;663. doi: 10.1111/joim.12816.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/joim.12816</ArticleId><ArticleId IdType="pubmed">30051512</ArticleId></ArticleIdList></Reference><Reference><Citation>Chatterjee P., Elmi M., Goozee K., Shah T., Sohrabi H.R., Dias C.B., Pedrini S., Shen K., Asih P.R., Dave P., et al. Ultrasensitive Detection of Plasma Amyloid-&#x3b2; as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2019;71:775&#x2013;783. doi: 10.3233/JAD-190533.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190533</ArticleId><ArticleId IdType="pubmed">31424403</ArticleId></ArticleIdList></Reference><Reference><Citation>&#xc1;lvarez-S&#xe1;nchez L., Pe&#xf1;a-Bautista C., Ferr&#xe9;-Gonz&#xe1;lez L., Balaguer A., Baquero M., Casanova-Estruch B., Ch&#xe1;fer-Peric&#xe1;s C. Assessment of Plasma and Cerebrospinal Fluid Biomarkers in Different Stages of Alzheimer&#x2019;s Disease and Frontotemporal Dementia. Int. J. Mol. Sci. 2023;24:1226. doi: 10.3390/ijms24021226.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24021226</ArticleId><ArticleId IdType="pmc">PMC9864037</ArticleId><ArticleId IdType="pubmed">36674742</ArticleId></ArticleIdList></Reference><Reference><Citation>Cho H.J., Schulz P., Venkataraman L., Caselli R.J., Sierks M.R. Sex-Specific Multiparameter Blood Test for the Early Diagnosis of Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2022;23:15670. doi: 10.3390/ijms232415670.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms232415670</ArticleId><ArticleId IdType="pmc">PMC9779188</ArticleId><ArticleId IdType="pubmed">36555310</ArticleId></ArticleIdList></Reference><Reference><Citation>Cullen N.C., Leuzy A., Janelidze S., Palmqvist S., Svenningsson A.L., Stomrud E., Dage J.L., Mattsson-Carlgren N., Hansson O. Plasma Biomarkers of Alzheimer&#x2019;s Disease Improve Prediction of Cognitive Decline in Cognitively Unimpaired Elderly Populations. Nat. Commun. 2021;12:3555. doi: 10.1038/s41467-021-23746-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-23746-0</ArticleId><ArticleId IdType="pmc">PMC8196018</ArticleId><ArticleId IdType="pubmed">34117234</ArticleId></ArticleIdList></Reference><Reference><Citation>Leuzy A., Mattsson-Carlgren N., Palmqvist S., Janelidze S., Dage J.L., Hansson O. Blood-based Biomarkers for Alzheimer&#x2019;s Disease. EMBO Mol. Med. 2022;14:e14408. doi: 10.15252/emmm.202114408.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202114408</ArticleId><ArticleId IdType="pmc">PMC8749476</ArticleId><ArticleId IdType="pubmed">34859598</ArticleId></ArticleIdList></Reference><Reference><Citation>Janelidze S., Palmqvist S., Leuzy A., Stomrud E., Verberk I.M.W., Zetterberg H., Ashton N.J., Pesini P., Sarasa L., Allu&#xe9; J.A., et al. Detecting Amyloid Positivity in Early Alzheimer&#x2019;s Disease Using Combinations of Plasma A&#x3b2;42/A&#x3b2;40 and P-tau. Alzheimer&#x2019;s Dement. 2022;18:283&#x2013;293. doi: 10.1002/alz.12395.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12395</ArticleId><ArticleId IdType="pubmed">34151519</ArticleId></ArticleIdList></Reference><Reference><Citation>Dubois B., Feldman H.H., Jacova C., Hampel H., Molinuevo J.L., Blennow K., DeKosky S.T., Gauthier S., Selkoe D., Bateman R., et al. Advancing research diagnostic criteria for Alzheimer&#x2019;s disease: The IWG-2 criteria. Lancet Neurol. 2014;13:614&#x2013;629. doi: 10.1016/S1474-4422(14)70090-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70090-0</ArticleId><ArticleId IdType="pubmed">24849862</ArticleId></ArticleIdList></Reference><Reference><Citation>Simonsen A.H., Herukka S.K., Andreasen N., Baldeiras I., Bjerke M., Blennow K., Engelborghs S., Frisoni G.B., Gabryelewicz T., Galluzzi S., et al. Recommendations for CSF AD biomarkers in the diagnostic evaluation of dementia. Alzheimer&#x2019;s Dement. 2017;13:274&#x2013;284. doi: 10.1016/j.jalz.2016.09.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.09.008</ArticleId><ArticleId IdType="pubmed">28341065</ArticleId></ArticleIdList></Reference><Reference><Citation>McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Jr., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., et al. The diagnosis of dementia due to Alzheimer&#x2019;s disease: Recommendations from the National Institute on Aging-Alzheimer&#x2019;s Association workgroups on diagnostic guidelines for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2011;7:263&#x2013;269. doi: 10.1016/j.jalz.2011.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2011.03.005</ArticleId><ArticleId IdType="pmc">PMC3312024</ArticleId><ArticleId IdType="pubmed">21514250</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamashita K., Miura M., Watanabe S., Ishiki K., Arimatsu Y., Kawahira J., Kubo T., Sasaki K., Arai T., Hagino K., et al. Fully Automated and Highly Specific Plasma &#x3b2;-Amyloid Immunoassays Predict &#x3b2;-Amyloid Status Defined by Amyloid Positron Emission Tomography with High Accuracy. Alzheimer&#x2019;s Res. Ther. 2022;14:86. doi: 10.1186/s13195-022-01029-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-022-01029-0</ArticleId><ArticleId IdType="pmc">PMC9219197</ArticleId><ArticleId IdType="pubmed">35739591</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke M.M., Aakre J.A., Algeciras-Schimnich A., Proctor N.K., Machulda M.M., Eichenlaub U., Knopman D.S., Vemuri P., Graff-Radford J., Jack C.R., Jr., et al. Comparison of CSF Phosphorylated Tau 181 and 217 for Cognitive Decline. Alzheimer&#x2019;s Dement. 2022;18:602&#x2013;611. doi: 10.1002/alz.12415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12415</ArticleId><ArticleId IdType="pmc">PMC8789950</ArticleId><ArticleId IdType="pubmed">34310832</ArticleId></ArticleIdList></Reference><Reference><Citation>Mielke M.M., Hagen C.E., Xu J., Chai X., Vemuri P., Lowe V.J., Airey D.C., Knopman D.S., Roberts R.O., Machulda M.M., et al. Plasma Phospho-Tau181 Increases with Alzheimer&#x2019;s Disease Clinical Severity and Is Associated with Tau- and Amyloid-Positron Emission Tomography. Alzheimer&#x2019;s Dement. 2018;14:989&#x2013;997. doi: 10.1016/j.jalz.2018.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.013</ArticleId><ArticleId IdType="pmc">PMC6097897</ArticleId><ArticleId IdType="pubmed">29626426</ArticleId></ArticleIdList></Reference><Reference><Citation>Tatebe H., Kasai T., Ohmichi T., Kishi Y., Kakeya T., Waragai M., Kondo M., Allsop D., Tokuda T. Quantification of Plasma Phosphorylated Tau to Use as a Biomarker for Brain Alzheimer Pathology: Pilot Case-Control Studies Including Patients with Alzheimer&#x2019;s Disease and down Syndrome. Mol. Neurodegener. 2017;12:63&#x2013;74. doi: 10.1186/s13024-017-0206-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-017-0206-8</ArticleId><ArticleId IdType="pmc">PMC5582385</ArticleId><ArticleId IdType="pubmed">28866979</ArticleId></ArticleIdList></Reference><Reference><Citation>West T., Kirmess K.M., Meyer M.R., Holubasch M.S., Knapik S.S., Hu Y., Contois J.H., Jackson E.N., Harpstrite S.E., Bateman R.J., et al. A blood-based diagnostic test incorporating plasma A&#x3b2;42/40 ratio, ApoE proteotype, and age accurately identifies brain amyloid status: Findings from a multi cohort validity analysis. Mol. Neurodegener. 2021;16:30. doi: 10.1186/s13024-021-00451-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-021-00451-6</ArticleId><ArticleId IdType="pmc">PMC8088704</ArticleId><ArticleId IdType="pubmed">33933117</ArticleId></ArticleIdList></Reference><Reference><Citation>Tissot C., Therriault J., Kunach P. Comparing tau status determined via plasma pTau181, pTau231 and [18F] MK6240 tau-PET. EBioMedicine. 2022;76:103837. doi: 10.1016/j.ebiom.2022.103837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ebiom.2022.103837</ArticleId><ArticleId IdType="pmc">PMC8844756</ArticleId><ArticleId IdType="pubmed">35134647</ArticleId></ArticleIdList></Reference><Reference><Citation>O&#x2019;Connor A., Karikari T.K., Poole T., Ashton N.J., Lantero Rodriguez J., Khatun A., Swift I., Heslegrave A.J., Abel E., Chung E., et al. Plasma Phospho-Tau181 in Presymptomatic and Symptomatic Familial Alzheimer&#x2019;s Disease: A Longitudinal Cohort Study. Mol. Psychiatry. 2021;26:5967&#x2013;5976. doi: 10.1038/s41380-020-0838-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-020-0838-x</ArticleId><ArticleId IdType="pmc">PMC7612227</ArticleId><ArticleId IdType="pubmed">32665603</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Calvet M., Karikari T.K., Ashton N.J., Lantero Rodr&#xed;guez J., Mil&#xe0;-Alom&#xe0; M., Gispert J.D., Salvad&#xf3; G., Minguillon C., Fauria K., Shekari M., et al. Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer&#x2019;s continuum when only subtle changes in A&#x3b2; pathology are detected. EMBO Mol. Med. 2020;12:e12921. doi: 10.15252/emmm.202012921.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.202012921</ArticleId><ArticleId IdType="pmc">PMC7721364</ArticleId><ArticleId IdType="pubmed">33169916</ArticleId></ArticleIdList></Reference><Reference><Citation>Barth&#xe9;lemy N.R., Li Y., Joseph-Mathurin N., Gordon B.A., Hassenstab J., Benzinger T.L.S., Buckles V., Fagan A.M., Perrin R.J., Goate A.M., et al. Dominantly Inherited Alzheimer Network. A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer&#x2019;s disease. Nat. Med. 2020;26:398&#x2013;407. doi: 10.1038/s41591-020-0781-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0781-z</ArticleId><ArticleId IdType="pmc">PMC7309367</ArticleId><ArticleId IdType="pubmed">32161412</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton N.J., Pascoal T.A., Karikari T.K., Benedet A.L., Lantero-Rodriguez J., Brinkmalm G., Snellman A., Sch&#xf6;ll M., Troakes C., Hye A., et al. Plasma p-tau231: A new biomarker for incipient Alzheimer&#x2019;s disease pathology. Acta Neuropathol. 2021;141:709&#x2013;724. doi: 10.1007/s00401-021-02275-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-021-02275-6</ArticleId><ArticleId IdType="pmc">PMC8043944</ArticleId><ArticleId IdType="pubmed">33585983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ashton N.J., Janelidze S., Mattsson-Carlgren N., Binette A.P., Strandberg O., Brum W.S., Karikari T.K., Gonz&#xe1;lez-Ortiz F., Di Molfetta G., Meda F.J., et al. Differential roles of A&#x3b2;42/40, p-tau231 and p-tau217 for Alzheimer&#x2019;s trial selection and disease monitoring. Nat. Med. 2022;28:2555&#x2013;2562. doi: 10.1038/s41591-022-02074-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-02074-w</ArticleId><ArticleId IdType="pmc">PMC9800279</ArticleId><ArticleId IdType="pubmed">36456833</ArticleId></ArticleIdList></Reference><Reference><Citation>Mil&#xe0;-Alom&#xe0; M., Ashton N.J., Shekari M., Salvad&#xf3; G., Ortiz-Romero P., Montoliu-Gaya L., Benedet A.L., Karikari T.K., Lantero-Rodriguez J., Vanmechelen E., et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-&#x3b2; pathology in preclinical Alzheimer&#x2019;s disease. Nat. Med. 2022;28:1797&#x2013;1801. doi: 10.1038/s41591-022-01925-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01925-w</ArticleId><ArticleId IdType="pmc">PMC9499867</ArticleId><ArticleId IdType="pubmed">35953717</ArticleId></ArticleIdList></Reference><Reference><Citation>Atik A., Stewart T., Zhang J. Alpha-Synuclein as a Biomarker for Parkinson&#x2019;s Disease. Brain Pathol. 2016;26:410&#x2013;418. doi: 10.1111/bpa.12370.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12370</ArticleId><ArticleId IdType="pmc">PMC6245641</ArticleId><ArticleId IdType="pubmed">26940058</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi M., Bradner J., Hancock A.M., Chung K.A., Quinn J.F., Peskind E.R., Galasko D., Jankovic J., Zabetian C.P., Kim H.M., et al. Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression. Ann. Neurol. 2011;69:570&#x2013;580. doi: 10.1002/ana.22311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.22311</ArticleId><ArticleId IdType="pmc">PMC3117674</ArticleId><ArticleId IdType="pubmed">21400565</ArticleId></ArticleIdList></Reference><Reference><Citation>Bougea A., Stefanis L., Paraskevas G.P., Emmanouilidou E., Vekrelis K., Kapaki E. Plasma &#x3b1;-synuclein levels in patients with Parkinson&#x2019;s disease: A systematic review and meta-analysis. Neurol. Sci. 2019;40:929&#x2013;938. doi: 10.1007/s10072-019-03738-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-019-03738-1</ArticleId><ArticleId IdType="pubmed">30715632</ArticleId></ArticleIdList></Reference><Reference><Citation>El-Agnaf O., Salem S.A., Paleologou K.E., Curran M.D., Gibson M.J., Court J.A., Schlossmacher M.G., Allsop D. Detection of oligomeric forms of &#x3b1;-synuclein protein in human plasma as a potential biomarker for Parkinson&#x2019;s disease. FASEB J. 2006;20:419&#x2013;425. doi: 10.1096/fj.03-1449com.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.03-1449com</ArticleId><ArticleId IdType="pubmed">16507759</ArticleId></ArticleIdList></Reference><Reference><Citation>Kang K.H., Liou H.H., Hour M.J., Liou H.C., Fu W.M. Protection of dopaminergic neurons by 5-lipoxygenase inhibitor. Neuropharmacology. 2013;73:380&#x2013;387. doi: 10.1016/j.neuropharm.2013.06.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropharm.2013.06.014</ArticleId><ArticleId IdType="pubmed">23800665</ArticleId></ArticleIdList></Reference><Reference><Citation>Iljina M., Dear A.J., Garcia G.A., De S., Tosatto L., Flagmeier P., Whiten D.R., Michaels T.C.T., Dobson D.F.C.M., Knowles T.P.J., et al. Quantifying co-oligomer formation by &#x3b1;-synuclein. ACS Nano. 2018;12:10855&#x2013;10866. doi: 10.1021/acsnano.8b03575.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.8b03575</ArticleId><ArticleId IdType="pmc">PMC6262461</ArticleId><ArticleId IdType="pubmed">30371053</ArticleId></ArticleIdList></Reference><Reference><Citation>Spires-Jones T.L., Attems J., Thal D.R. Interactions of pathological proteins in neurodegenerative diseases. Acta Neuropathol. 2017;134:187&#x2013;205. doi: 10.1007/s00401-017-1709-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1709-7</ArticleId><ArticleId IdType="pmc">PMC5508034</ArticleId><ArticleId IdType="pubmed">28401333</ArticleId></ArticleIdList></Reference><Reference><Citation>Galpern W.R., Lang A.E. Interface between tauopathies and synucleinopathies: A tale of two proteins. Ann. Neurol. 2006;59:449&#x2013;458. doi: 10.1002/ana.20819.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20819</ArticleId><ArticleId IdType="pubmed">16489609</ArticleId></ArticleIdList></Reference><Reference><Citation>Emin D., Zhang Y.P., Lobanova E., Miller A., Li X., Xia Z., Dakin H., Sideris D.I., Lam J.Y.L., Ranasinghe R.T., et al. Small soluble &#x3b1;-synuclein aggregates are the toxic species in Parkinson&#x2019;s disease. Nat. Commun. 2022;13:5512. doi: 10.1038/s41467-022-33252-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33252-6</ArticleId><ArticleId IdType="pmc">PMC9489799</ArticleId><ArticleId IdType="pubmed">36127374</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnetti L., Chiasserini D., Persichetti E., Eusebi P., Varghese S., Qureshi M.M., Dardis A., Deganuto M., De Carlo C., Castrioto A., et al. Cerebrospinal fluid lysosomal enzymes and &#x3b1;-synuclein in Parkinson&#x2019;s disease. Mov. Disord. 2014;29:1019&#x2013;1027. doi: 10.1002/mds.25772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.25772</ArticleId><ArticleId IdType="pmc">PMC4282452</ArticleId><ArticleId IdType="pubmed">24436092</ArticleId></ArticleIdList></Reference><Reference><Citation>Parnetti L., Farotti L., Eusebi P., Chiasserini D., De Carlo C., Giannandrea D., Salvadori N., Lisetti V., Tambasco N., Rossi A., et al. Differential role of CSF &#x3b1;-synuclein species, tau, and A&#x3b2;42 in Parkinson&#x2019;s Disease. Front. Aging Neurosci. 2014;6:53. doi: 10.3389/fnagi.2014.00053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00053</ArticleId><ArticleId IdType="pmc">PMC3978246</ArticleId><ArticleId IdType="pubmed">24744728</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Liu X., Zhong Y. Interleukin-17A: The Key Cytokine in Neurodegenerative Diseases. Front. Aging Neurosci. 2020;12:566922. doi: 10.3389/fnagi.2020.566922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2020.566922</ArticleId><ArticleId IdType="pmc">PMC7550684</ArticleId><ArticleId IdType="pubmed">33132897</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng A.S.L., Tan Y.J., Yong A.C.W., Saffari S.E., Lu Z., Ng E.Y., Ng S.Y.E., Chia N.S.Y., Choi X., Heng D., et al. Utility of plasma Neurofilament light as a diagnostic and prognostic biomarker of the postural instability gait disorder motor subtype in early Parkinson&#x2019;s disease. Mol. Neurodegener. 2020;15:33. doi: 10.1186/s13024-020-00385-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13024-020-00385-5</ArticleId><ArticleId IdType="pmc">PMC7275464</ArticleId><ArticleId IdType="pubmed">32503574</ArticleId></ArticleIdList></Reference><Reference><Citation>Hazy E., Bokor M., Kalmar L., Gelencser A., Kamasa P., Han K.H., Tompa K., Tompa P. Distinct hydration properties of wild-type and familial point mutant A53T of a-synuclein associated with Parkinson&#x2019;s disease. Biophys. J. 2011;101:2260&#x2013;2266. doi: 10.1016/j.bpj.2011.08.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2011.08.052</ArticleId><ArticleId IdType="pmc">PMC3207174</ArticleId><ArticleId IdType="pubmed">22067166</ArticleId></ArticleIdList></Reference><Reference><Citation>Krisko A., Radman M. Protein damage, ageing and age-related diseases. Open Biol. 2019;9:180249. doi: 10.1098/rsob.180249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1098/rsob.180249</ArticleId><ArticleId IdType="pmc">PMC6451363</ArticleId><ArticleId IdType="pubmed">30914006</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkins H.M., Dimachkie M.M., Agbas A. Blood-based Biomarkers for Amyotrophic Lateral Sclerosis. In: Araki T., editor. Amyotrophic Lateral Sclerosis. Exon Publications; Brisbane, Australia: 2021. pp. 105&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pubmed">34473438</ArticleId></ArticleIdList></Reference><Reference><Citation>Savage N. Calculating disease. Nature. 2017;550:S115&#x2013;S117. doi: 10.1038/550S115a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/550S115a</ArticleId><ArticleId IdType="pubmed">29045372</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T., Tokuda T., Ishigami N., Sasayama H., Foulds P., Mitchell D.J., Mann D.M.A. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol. 2009;117:55&#x2013;62. doi: 10.1007/s00401-008-0456-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-008-0456-1</ArticleId><ArticleId IdType="pubmed">18989684</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambino C.M., Ciaccio A.M., Lo Sasso B., Giglio R.V., Vidali M., Agnello L., Ciaccio M. The Role of TAR DNA Binding Protein 43 (TDP-43) as a CandiDate Biomarker of Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis. Diagnostics. 2023;13:416. doi: 10.3390/diagnostics13030416.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics13030416</ArticleId><ArticleId IdType="pmc">PMC9914415</ArticleId><ArticleId IdType="pubmed">36766521</ArticleId></ArticleIdList></Reference><Reference><Citation>Lind A.-L., Wu D., Freyhult E., Bodolea C., Ekegren T., Larssson A., Gustafsson M.G., Katila L., Bergquist J., Gordh T., et al. A multiplex protein panel applied to cerebrospinal fluid reveals three new biomarker candidates in ALS but none in neuropathic pain patients. PLoS ONE. 2016;11:e0149821. doi: 10.1371/journal.pone.0149821.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0149821</ArticleId><ArticleId IdType="pmc">PMC4767403</ArticleId><ArticleId IdType="pubmed">26914813</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H., Jacobsson J., Rosengren L., Blennow K., Andersen P.M. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: Impact of SOD1 genotype. Eur. J. Neurol. 2007;14:1329&#x2013;1333. doi: 10.1111/j.1468-1331.2007.01972.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1468-1331.2007.01972.x</ArticleId><ArticleId IdType="pubmed">17903209</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu C.H., Macdonald-Wallis C., Gray E., Pearce N., Petzold A., Norgren N., Giovannoni G., Fratta P., Sidle K., Fish M., et al. Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis. Neurology. 2015;84:2247&#x2013;2257. doi: 10.1212/WNL.0000000000001642.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001642</ArticleId><ArticleId IdType="pmc">PMC4456658</ArticleId><ArticleId IdType="pubmed">25934855</ArticleId></ArticleIdList></Reference><Reference><Citation>Lanznaster D., Hergesheimer R.C., Bakkouche S.E., Beltran S., Vourch P., Andres C.R., Dufour-Rainfray D., Corcia P., Blasco H. A&#x3b2;1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis. Int. J. Mol. Sci. 2020;21:2911. doi: 10.3390/ijms21082911.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21082911</ArticleId><ArticleId IdType="pmc">PMC7216266</ArticleId><ArticleId IdType="pubmed">32326346</ArticleId></ArticleIdList></Reference><Reference><Citation>Manzo E., Lorenzini I., Barrameda D., O&#x2019;Conner A.G., Barrows J.M., Starr A., Kovalik T., Rabichow B.E., Lehmkuhl E.M., Shreiner D.D., et al. Glycolysis upregulation is neuroprotective as a compensatory mechanism in ALS. eLife. 2019;8:e45114. doi: 10.7554/eLife.45114.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.45114</ArticleId><ArticleId IdType="pmc">PMC6557627</ArticleId><ArticleId IdType="pubmed">31180318</ArticleId></ArticleIdList></Reference><Reference><Citation>Wuolikainen A., Jonsson P., Ahnlund M., Antti H., Marklund S.L., Moritz T., Forsgren L., Andersen P.M., Trupp M. Multi-platform mass spectrometry analysis of the CSF and plasma metabolomes of rigorously matched amyotrophic lateral sclerosis, Parkinson&#x2019;s disease and control subjects. Mol. Biosyst. 2016;12:1287&#x2013;1298. doi: 10.1039/C5MB00711A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5MB00711A</ArticleId><ArticleId IdType="pubmed">26883206</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen D.R., Siddique T., Patterson D., Figlewicz D.A., Sapp P., Hentati A., Donaldson D., Goto J., O&#x2019;Regan J.P., Deng H.X., et al. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 1993;362:59&#x2013;62. doi: 10.1038/362059a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/362059a0</ArticleId><ArticleId IdType="pubmed">8446170</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N., Shaw P.J. Biomarkers in amyotrophic lateral sclerosis: A review of new developments. Curr. Opin. Neurol. 2020;33:662&#x2013;668. doi: 10.1097/WCO.0000000000000854.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000854</ArticleId><ArticleId IdType="pubmed">32796280</ArticleId></ArticleIdList></Reference><Reference><Citation>Verber N.S., Shepheard S.R., Sassani M., McDonough H.E., Moore S.A., Alix J.J.P., Wilkinson I.D., Jenkins T.M., Shaw P.J. Biomarkers in Motor Neuron Disease: A State of the Art Review. Front. Neurol. 2019;10:291. doi: 10.3389/fneur.2019.00291.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2019.00291</ArticleId><ArticleId IdType="pmc">PMC6456669</ArticleId><ArticleId IdType="pubmed">31001186</ArticleId></ArticleIdList></Reference><Reference><Citation>Lunetta C., Moglia C., Lizio A., Caponnetto C., Dubbioso R., Giannini F., Mat&#xe0; S., Mazzini L., Sabatelli M., Siciliano G., et al. The Italian multicenter experience with edaravone in amyotrophic lateral sclerosis. J. Neurol. 2020;267:3258&#x2013;3267. doi: 10.1007/s00415-020-09993-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-020-09993-z</ArticleId><ArticleId IdType="pubmed">32556567</ArticleId></ArticleIdList></Reference><Reference><Citation>Poesen K., Van Damme P. Diagnostic and prognostic performance of neurofilaments in ALS. Front. Neurol. 2018;9:1167. doi: 10.3389/fneur.2018.01167.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.01167</ArticleId><ArticleId IdType="pmc">PMC6345692</ArticleId><ArticleId IdType="pubmed">30713520</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbo M., Ravnik-Glava&#x10d; M. Extracellular Vesicles as Potential Biomarkers in Amyotrophic Lateral Sclerosis. Genes. 2023;14:325. doi: 10.3390/genes14020325.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/genes14020325</ArticleId><ArticleId IdType="pmc">PMC9956314</ArticleId><ArticleId IdType="pubmed">36833252</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaiani A., Martinelli I., Bello L., Querin G., Puthenparampil M., Ruggero S., Toffanin E., Cagnin A., Briani C., Pegoraro E., et al. Diagnostic and prognostic biomarkers in amyotrophic lateral sclerosis: Neurofilament light chain levels in definite subtypes of disease. JAMA Neurol. 2017;74:525&#x2013;532. doi: 10.1001/jamaneurol.2016.5398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2016.5398</ArticleId><ArticleId IdType="pmc">PMC5822207</ArticleId><ArticleId IdType="pubmed">28264096</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Steinacker P., Weishaupt J.H., Kassubek J., Oeckl P., Halbgebauer S., Tumani H., von Arnim C.A.F., Dorst J., Feneberg E., et al. Neurofilament light chain in serum for the diagnosis of amyotrophic lateral sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019;90:157&#x2013;164. doi: 10.1136/jnnp-2018-318704.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-318704</ArticleId><ArticleId IdType="pubmed">30309882</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirano A., Donnenfeld H., Sasaki S., Nakano I. Fine Structural Observations of Neurofilamentous Changes in Amyotrophic Lateral Sclerosis. J. Neuropathol. Exp. Neurol. 1984;43:461&#x2013;470. doi: 10.1097/00005072-198409000-00001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005072-198409000-00001</ArticleId><ArticleId IdType="pubmed">6540799</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe P.A., Pfluger C., Singh P., Lim C.Y., Airey C., Henderson R.D. Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. J. Neurol. Sci. 2015;353:122&#x2013;129. doi: 10.1016/j.jns.2015.04.032.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2015.04.032</ArticleId><ArticleId IdType="pubmed">25958264</ArticleId></ArticleIdList></Reference><Reference><Citation>Kasai T., Kojima Y., Ohmichi T., Tatebe H., Tsuji Y., Noto Y.I., Kitani-Morii F., Shinomoto M., Allsop D., Mizuno T., et al. Combined use of CSF NfL and CSF TDP-43 improves diagnostic performance in ALS. Ann. Clin. Transl. Neurol. 2019;6:2489&#x2013;2502. doi: 10.1002/acn3.50943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.50943</ArticleId><ArticleId IdType="pmc">PMC6917342</ArticleId><ArticleId IdType="pubmed">31742901</ArticleId></ArticleIdList></Reference><Reference><Citation>Oeckl P., Jardel C., Salachas F., Lamari F., Andersen P.M., Bowser R., de Carvalho M., Costa J., van Damme P., Gray E., et al. Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS. Amyotroph. Lateral Scler. Front. Degener. 2016;17:404&#x2013;413. doi: 10.3109/21678421.2016.1167913.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2016.1167913</ArticleId><ArticleId IdType="pubmed">27415180</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H., Skillb&#xe4;ck T., Mattsson N., Trojanowski J.Q., Portelius E., Shaw L.M., Weiner M.W., Blennow K. Association of Cerebrospinal Fluid Neurofilament Light Concentration with Alzheimer Disease Progression. JAMA Neurol. 2016;73:60&#x2013;67. doi: 10.1001/jamaneurol.2015.3037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.3037</ArticleId><ArticleId IdType="pmc">PMC5624219</ArticleId><ArticleId IdType="pubmed">26524180</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;ckstr&#xf6;m D.C., Domell&#xf6;f M.E., Linder J., Olsson B., &#xd6;hrfelt A., Trupp M., Zetterberg H., Blennow K., Forsgren L. Cerebrospinal fluid patterns and the risk of future dementia in early, incident Parkinson disease. JAMA Neurol. 2015;72:1175&#x2013;1182. doi: 10.1001/jamaneurol.2015.1449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2015.1449</ArticleId><ArticleId IdType="pubmed">26258692</ArticleId></ArticleIdList></Reference><Reference><Citation>Kojima Y., Kasai T., Noto Y.I., Ohmichi T., Tatebe H., Kitaoji T., Tsuji Y., Kitani-Morii F., Shinomoto M., Allsop D., et al. Amyotrophic lateral sclerosis: Correlations between fluid biomarkers of NfL, TDP-43, and tau, and clinical characteristics. PLoS ONE. 2021;16:e0260323. doi: 10.1371/journal.pone.0260323.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0260323</ArticleId><ArticleId IdType="pmc">PMC8629269</ArticleId><ArticleId IdType="pubmed">34843548</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Carrero J.J., Zagai U., Evans M., Ingre C., Pawitan Y., Fang F. Blood biomarkers and prognosis of amyotrophic lateral sclerosis. Eur. J. Neurol. 2020;27:2125&#x2013;2133. doi: 10.1111/ene.14409.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.14409</ArticleId><ArticleId IdType="pubmed">32557963</ArticleId></ArticleIdList></Reference><Reference><Citation>Colletti T., Agnello L., Spataro R., Guccione L., Notaro A., Lo Sasso B., Blandino V., Graziano F., Gambino C.M., Giglio R.V., et al. Prognostic Role of CSF &#x3b2;-amyloid 1&#x2013;42/1&#x2013;40 Ratio in Patients Affected by Amyotrophic Lateral Sclerosis. Brain Sci. 2021;11:302. doi: 10.3390/brainsci11030302.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11030302</ArticleId><ArticleId IdType="pmc">PMC7997395</ArticleId><ArticleId IdType="pubmed">33673569</ArticleId></ArticleIdList></Reference><Reference><Citation>Sol J., Jov&#xe9; M., Povedano M., Sproviero W., Dom&#xed;nguez R., Pi&#xf1;ol-Ripoll G., Romero-Guevara R., Hye A., Al-Chalabi A., Torres P., et al. Lipidomic traits of plasma and cerebrospinal fluid in amyotrophic lateral sclerosis correlate with disease progression. Brain Commun. 2021;3:fcab143. doi: 10.1093/braincomms/fcab143.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcab143</ArticleId><ArticleId IdType="pmc">PMC8361390</ArticleId><ArticleId IdType="pubmed">34396104</ArticleId></ArticleIdList></Reference><Reference><Citation>Area-Gomez E., Larrea D., Yun T., Xu Y., Hupf J., Zandkarimi F., Chan R.B., Mitsumoto H. Lipidomics study of plasma from patients suggest that ALS and PLS are part of a continuum of motor neuron disorders. Sci. Rep. 2021;11:13562. doi: 10.1038/s41598-021-92112-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92112-3</ArticleId><ArticleId IdType="pmc">PMC8245424</ArticleId><ArticleId IdType="pubmed">34193885</ArticleId></ArticleIdList></Reference><Reference><Citation>Mariosa D., Hammar N., Malmstr&#xf6;m H., Ingre C., Jungner I., Ye W., Fang F., Walldius G. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year followup of the Swedish AMORIS cohort. Ann. Neurol. 2017;81:718&#x2013;728. doi: 10.1002/ana.24936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24936</ArticleId><ArticleId IdType="pubmed">28437840</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandres-Ciga S., Noyce A.J., Hemani G., Nicolas A., Calvo A., Mora G., ITALSGEN Consortium. International ALS Genomics Consortium. Tienari P.J., Stone D.J., et al. Shared polygenic risk and causal inferences in amyotrophic lateral sclerosis. Ann. Neurol. 2019;85:470&#x2013;481. doi: 10.1002/ana.25431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25431</ArticleId><ArticleId IdType="pmc">PMC6450729</ArticleId><ArticleId IdType="pubmed">30723964</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty A., Diwan A. Biomarkers and molecular mechanisms of Amyotrophic Lateral Sclerosis. AIMS Neurosci. 2022;9:423&#x2013;443. doi: 10.3934/Neuroscience.2022023.</Citation><ArticleIdList><ArticleId IdType="doi">10.3934/Neuroscience.2022023</ArticleId><ArticleId IdType="pmc">PMC9826749</ArticleId><ArticleId IdType="pubmed">36660079</ArticleId></ArticleIdList></Reference><Reference><Citation>Periayah M.H., Halim A.S., Mat Saad A.Z. Mechanism Action of Platelets and Crucial Blood Coagulation Pathways in Hemostasis. Int. J. Hematol. Oncol. Stem Cell Res. 2017;11:319&#x2013;327.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5767294</ArticleId><ArticleId IdType="pubmed">29340130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko&#xe7;er A., Yaman A., Niftaliyev E., D&#xfc;r&#xfc;yen H., Ery&#x131;lmaz M., Ko&#xe7;er E. Assessment of platelet indices in patients with neurodegenerative diseases: Mean platelet volume was increased in patients with Parkinson&#x2019;s disease. Curr. Gerontol. Geriatr. Res. 2013;2013:986254. doi: 10.1155/2013/986254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/986254</ArticleId><ArticleId IdType="pmc">PMC3870626</ArticleId><ArticleId IdType="pubmed">24382959</ArticleId></ArticleIdList></Reference><Reference><Citation>Behari M., Shrivastava M. Role of platelets in neurodegenerative diseases: A universal pathophysiology. Int. J. Neurosci. 2013;123:287&#x2013;299. doi: 10.3109/00207454.2012.751534.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00207454.2012.751534</ArticleId><ArticleId IdType="pubmed">23301959</ArticleId></ArticleIdList></Reference><Reference><Citation>Holinstat M. Normal platelet function. Cancer Metastasis Rev. 2017;36:195&#x2013;198. doi: 10.1007/s10555-017-9677-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10555-017-9677-x</ArticleId><ArticleId IdType="pmc">PMC5709181</ArticleId><ArticleId IdType="pubmed">28667366</ArticleId></ArticleIdList></Reference><Reference><Citation>Burnouf T., Walker T.L. The multifaceted role of platelets in mediating brain function. Blood. 2022;140:815&#x2013;827. doi: 10.1182/blood.2022015970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2022015970</ArticleId><ArticleId IdType="pmc">PMC9412009</ArticleId><ArticleId IdType="pubmed">35609283</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter O., Walker T.L. Platelets in Neurodegenerative Conditions&#x2014;Friend or Foe? Front. Immun. 2020;11:747. doi: 10.3389/fimmu.2020.00747.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00747</ArticleId><ArticleId IdType="pmc">PMC7214916</ArticleId><ArticleId IdType="pubmed">32431701</ArticleId></ArticleIdList></Reference><Reference><Citation>Kiktenko A.I., Zlobina G.P., Brusov O.S., Zakharova M.N. Structure of peripheral blood platelets surface in patients with amyotrophic lateral sclerosis and multiple sclerosis. Zhurnal Nevrol. i Psikhiatrii Im. SS Korsakova. 2005;105:40&#x2013;42.</Citation><ArticleIdList><ArticleId IdType="pubmed">15822741</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim K.M., Kim H.H., Bae O.N., Noh J.Y., Kim K.Y., Kim S.H., Chung S.M., Shin S., Kim H.Y., Chung J.H. Inhibition of platelet aggregation by 1-methyl-4-phenyl pyridinium ion (MPP+) through ATP depletion: Evidence for the reduced platelet activities in Parkinson&#x2019;s disease. Platelets. 2009;20:163&#x2013;170. doi: 10.1080/09537100902721746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537100902721746</ArticleId><ArticleId IdType="pubmed">19437333</ArticleId></ArticleIdList></Reference><Reference><Citation>Stellos K., Panagiota V., K&#xf6;gel A., Leyhe T., Gawaz M., Laske C. Predictive value of platelet activation for the rate of cognitive decline in Alzheimer&#x2019;s disease patients. J. Cereb. Blood Flow Metab. 2010;30:1817&#x2013;1820. doi: 10.1038/jcbfm.2010.140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/jcbfm.2010.140</ArticleId><ArticleId IdType="pmc">PMC3023934</ArticleId><ArticleId IdType="pubmed">20717123</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa-Parrilla Y., Gonzalez-Billault C., Fuentes E., Palomo I., Alarc&#xf3;n M. Decoding the Role of Platelets and Related MicroRNAs in Aging and Neurodegenerative Disorders. Front. Aging Neurosci. 2019;11:151. doi: 10.3389/fnagi.2019.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2019.00151</ArticleId><ArticleId IdType="pmc">PMC6614495</ArticleId><ArticleId IdType="pubmed">31312134</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaninetti C., Sachs L., Palankar R. Role of Platelet Cytoskeleton in Platelet Biomechanics: Current and Emerging Methodologies and Their Potential Relevance for the Investigation of Inherited Platelet Disorders. Hamostaseologie. 2020;40:337&#x2013;347. doi: 10.1055/a-1175-6783.</Citation><ArticleIdList><ArticleId IdType="doi">10.1055/a-1175-6783</ArticleId><ArticleId IdType="pubmed">32726828</ArticleId></ArticleIdList></Reference><Reference><Citation>Winokur R., Hartwig J.H. Mechanism of shape change in chilled human platelets. Blood. 1995;85:1796&#x2013;1804. doi: 10.1182/blood.V85.7.1796.bloodjournal8571796.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V85.7.1796.bloodjournal8571796</ArticleId><ArticleId IdType="pubmed">7703486</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig J.H. Mechanisms of actin rearrangements mediating platelet activation. J. Cell Biol. 1992;118:1421&#x2013;1442. doi: 10.1083/jcb.118.6.1421.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.118.6.1421</ArticleId><ArticleId IdType="pmc">PMC2289606</ArticleId><ArticleId IdType="pubmed">1325975</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartwig J.H. The platelet: Form and function. Semin. Hematol. 2006;43:S94&#x2013;S100. doi: 10.1053/j.seminhematol.2005.11.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.seminhematol.2005.11.004</ArticleId><ArticleId IdType="pubmed">16427392</ArticleId></ArticleIdList></Reference><Reference><Citation>Loftus J.C., Choate J., Albrecht R.M. Platelet activation and cytoskeletal reorganization: High voltage electron microscopic examination of intact and Triton-extracted whole mounts. J. Cell Biol. 1984;98:2019&#x2013;2025. doi: 10.1083/jcb.98.6.2019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.98.6.2019</ArticleId><ArticleId IdType="pmc">PMC2113056</ArticleId><ArticleId IdType="pubmed">6539337</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones C.I. Platelet function and ageing. Mammal. Genome. 2016;27:358&#x2013;366. doi: 10.1007/s00335-016-9629-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00335-016-9629-8</ArticleId><ArticleId IdType="pmc">PMC4935731</ArticleId><ArticleId IdType="pubmed">27068925</ArticleId></ArticleIdList></Reference><Reference><Citation>Montenont E., Rondina M.T., Campbell R.A. Altered functions of platelets during aging HHS Public Access. Curr. Opin. Hematol. 2019;26:336&#x2013;342. doi: 10.1097/MOH.0000000000000526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MOH.0000000000000526</ArticleId><ArticleId IdType="pmc">PMC7039178</ArticleId><ArticleId IdType="pubmed">31348047</ArticleId></ArticleIdList></Reference><Reference><Citation>Segal J.B., Moliterno A.R. Platelet counts differ by sex, ethnicity, and age in the United States. Ann. Epidemiol. 2006;16:123&#x2013;130. doi: 10.1016/j.annepidem.2005.06.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annepidem.2005.06.052</ArticleId><ArticleId IdType="pubmed">16246584</ArticleId></ArticleIdList></Reference><Reference><Citation>Bush A.I., Martins R.N., Rumble B., Moir R., Fuller S., Milward E., Currie J., Ames D., Weidemann A., Fischer P., et al. The amyloid precursor protein of Alzheimer&#x2019;s disease is released by human platelets. J. Biol. Chem. 1990;265:15977&#x2013;15983. doi: 10.1016/S0021-9258(18)55493-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0021-9258(18)55493-4</ArticleId><ArticleId IdType="pubmed">2118534</ArticleId></ArticleIdList></Reference><Reference><Citation>Catricala S., Torti M., Ricevuti G. Alzheimer disease and platelets: How&#x2019;s that relevant. Immun. Ageing. 2012;9:20. doi: 10.1186/1742-4933-9-20.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-4933-9-20</ArticleId><ArticleId IdType="pmc">PMC3545835</ArticleId><ArticleId IdType="pubmed">22985434</ArticleId></ArticleIdList></Reference><Reference><Citation>Mukaetova-Ladinska E., Abdell-All Z., Andrade J., Da Silva J., Boksha I., Burbaeva G., Kalaria R.N., Brien J.T.O. Platelet tau protein as a potential peripheral biomarker in Alzheimer&#x2019;s disease: An explorative study. Curr. Alzheimer Res. 2013;15:800&#x2013;808. doi: 10.2174/1567205015666180404165915.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205015666180404165915</ArticleId><ArticleId IdType="pubmed">29623842</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinhard C., H&#xe9;bert S.S., De Strooper B. The amyloid-&#x3b2; precursor protein: Integrating structure with biological function. EMBO J. 2005;24:3996&#x2013;4006. doi: 10.1038/sj.emboj.7600860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/sj.emboj.7600860</ArticleId><ArticleId IdType="pmc">PMC1356301</ArticleId><ArticleId IdType="pubmed">16252002</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrer-Raventos P., Beyer K. Alternative platelet activation pathways and their role in neurodegenerative diseases. Neurobiol. Dis. 2021;159:105512. doi: 10.1016/j.nbd.2021.105512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2021.105512</ArticleId><ArticleId IdType="pubmed">34537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Canobbio I., Catrical&#xe0; S., Di Pasqua L.G., Guidetti G., Consonni A., Manganaro D., Torti M. Immobilized amyloid A&#x3b2; peptides support platelet adhesion and activation. FEBS Lett. 2013;587:2606&#x2013;2611. doi: 10.1016/j.febslet.2013.06.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.febslet.2013.06.041</ArticleId><ArticleId IdType="pubmed">23831058</ArticleId></ArticleIdList></Reference><Reference><Citation>Donner L., Elvers M. Platelets and neurodegenerative diseases. In: Gresele P., Kleiman N.S., Lopez J.A., Page C.P., editors. Thrombotic and Non-Thrombotic Disorders: Pathophysiology, Pharmacology and Therapeutics: An Update. Springer International Publishing; Cham, Switzerland: 2017. pp. 1209&#x2013;1224.</Citation></Reference><Reference><Citation>Blass J.P., Gibson G.E. Nonneural Markers in Alzheimer Disease. Alzheimer Dis. Assoc. Disord. 1992;6:205&#x2013;224. doi: 10.1097/00002093-199206040-00003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002093-199206040-00003</ArticleId><ArticleId IdType="pubmed">1290624</ArticleId></ArticleIdList></Reference><Reference><Citation>Briones M.R.S., Snyder A.M., Ferreira R.C., Neely E.B., Connor J.R., Broach J.R. A possible role for platelet-activating factor receptor in amyotrophic lateral sclerosis treatment. Front. Neurol. 2018;9:39. doi: 10.3389/fneur.2018.00039.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00039</ArticleId><ArticleId IdType="pmc">PMC5810282</ArticleId><ArticleId IdType="pubmed">29472887</ArticleId></ArticleIdList></Reference><Reference><Citation>Dantzer R. Neuroimmune interactions: From the brain to the immune system and vice versa. Physiol. Rev. 2018;98:477&#x2013;504. doi: 10.1152/physrev.00039.2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/physrev.00039.2016</ArticleId><ArticleId IdType="pmc">PMC5866360</ArticleId><ArticleId IdType="pubmed">29351513</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbour R., Kling K., Anderson J.P., Banducci K., Cole T., Diep L., Fox M., Goldstein J.M., Soriano F., Seubert P., et al. Red blood cells are the major source of &#x3b1;-synuclein in blood. Neurodegener. Dis. 2008;5:55&#x2013;59. doi: 10.1159/000112832.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000112832</ArticleId><ArticleId IdType="pubmed">18182779</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu L.J., Sagara Y., Arroyo A., Rockenstein E., Sisk A., Mallory M., Wong J., Takenouchi T., Hashimoto M., Masliah E. &#x3b1;-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 2000;157:401&#x2013;410. doi: 10.1016/S0002-9440(10)64553-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-9440(10)64553-1</ArticleId><ArticleId IdType="pmc">PMC1850140</ArticleId><ArticleId IdType="pubmed">10934145</ArticleId></ArticleIdList></Reference><Reference><Citation>Pei Y., Maitta R.W. Alpha synuclein in hematopoiesis and immunity. Heliyon. 2019;5:e02590. doi: 10.1016/j.heliyon.2019.e02590.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heliyon.2019.e02590</ArticleId><ArticleId IdType="pmc">PMC6806402</ArticleId><ArticleId IdType="pubmed">31692680</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Spreux-Varoquaux O., Bensimon G., Jullien P., Lacomblez L., Salachas F., Bruneteau G., Pradat P.F., Loeffler J.P., Meininger V. Platelet serotonin level predicts survival in amyotrophic lateral sclerosis. PLoS ONE. 2010;5:e13346. doi: 10.1371/journal.pone.0013346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013346</ArticleId><ArticleId IdType="pmc">PMC2954194</ArticleId><ArticleId IdType="pubmed">20967129</ArticleId></ArticleIdList></Reference><Reference><Citation>Sevush S., Jy W., Horstman L.L., Mao W.W., Kolodny L., Ahn Y.S. Platelet activation in Alzheimer disease. Arch. Neurol. 1998;55:530&#x2013;536. doi: 10.1001/archneur.55.4.530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneur.55.4.530</ArticleId><ArticleId IdType="pubmed">9561982</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotnikov I., Veremeyko T., Starossom S.C., Barteneva N., Weiner H.L., Ponomarev E.D. Platelets recognize brain-specific glycolipid structures, respond to neurovascular damage and promote neuroinflammation. PLoS ONE. 2013;8:e58979. doi: 10.1371/journal.pone.0058979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0058979</ArticleId><ArticleId IdType="pmc">PMC3608633</ArticleId><ArticleId IdType="pubmed">23555611</ArticleId></ArticleIdList></Reference><Reference><Citation>Leiter O., Walker T.L. Platelets: The missing link between the blood and brain? Prog. Neurobiol. 2019;183:101695. doi: 10.1016/j.pneurobio.2019.101695.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2019.101695</ArticleId><ArticleId IdType="pubmed">31550515</ArticleId></ArticleIdList></Reference><Reference><Citation>Perello M., Stuart R., Nillni E.A. Prothyrotropin-releasing hormone targets its processing products to different vesicles of the secretory pathway. J. Biol. Chem. 2008;283:19936&#x2013;19947. doi: 10.1074/jbc.M800732200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M800732200</ArticleId><ArticleId IdType="pmc">PMC2459294</ArticleId><ArticleId IdType="pubmed">18474603</ArticleId></ArticleIdList></Reference><Reference><Citation>Italiano J.E., Richardson J.L., Patel-Hett S., Battinelli E., Zaslavsky A., Short S., Ryeom S., Folkman J., Klement G.L. Angiogenesis is regulated by a novel mechanism: Pro- and antiangiogenic proteins are organized into separate platelet &#x3b1;-granules and differentially released. Blood. 2008;111:1227&#x2013;1233. doi: 10.1182/blood-2007-09-113837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2007-09-113837</ArticleId><ArticleId IdType="pmc">PMC2214735</ArticleId><ArticleId IdType="pubmed">17962514</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yuan Y., Li W. Sorting machineries: How platelet-dense granules differ from &#x3b1;-granules. Biosci. Rep. 2018;38:BSR20180458. doi: 10.1042/BSR20180458.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BSR20180458</ArticleId><ArticleId IdType="pmc">PMC6127676</ArticleId><ArticleId IdType="pubmed">30104399</ArticleId></ArticleIdList></Reference><Reference><Citation>Ambrosio A.L., Di Pietro S.M. Storage pool diseases illuminate platelet dense granule biogenesis. Platelets. 2017;8:138&#x2013;146. doi: 10.1080/09537104.2016.1243789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09537104.2016.1243789</ArticleId><ArticleId IdType="pmc">PMC5994342</ArticleId><ArticleId IdType="pubmed">27849413</ArticleId></ArticleIdList></Reference><Reference><Citation>Heijnen H.F., Schiel A.E., Fijnheer R., Geuze H.J., Sixma J.J. Activated platelets release two types of membrane vesicles: Microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and &#x3b1;-granules. Blood. 1999;94:3791&#x2013;3799. doi: 10.1182/blood.V94.11.3791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V94.11.3791</ArticleId><ArticleId IdType="pubmed">10572093</ArticleId></ArticleIdList></Reference><Reference><Citation>Conway M.E. Alzheimer&#x2019;s disease: Targeting the glutamatergic system. Biogerontology. 2020;21:257&#x2013;274. doi: 10.1007/s10522-020-09860-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10522-020-09860-4</ArticleId><ArticleId IdType="pmc">PMC7196085</ArticleId><ArticleId IdType="pubmed">32048098</ArticleId></ArticleIdList></Reference><Reference><Citation>Lovino L., Tremblay M.E., Civiero L. Glutamate-induced excitotoxicity in Parkinson&#x2019;s disease: The role of glial cells. J. Pharm. Sci. 2020;144:151&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">32807662</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao J.S., Hanta&#xef; D., Festoff B.W. Thrombospondin, a platelet &#x3b1;-granule and matrix glycoprotein, is increased in muscle basement membrane of patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1992;113:99&#x2013;107. doi: 10.1016/0022-510X(92)90271-L.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(92)90271-L</ArticleId><ArticleId IdType="pubmed">1281872</ArticleId></ArticleIdList></Reference><Reference><Citation>Smirnova I.V., Festoff B.W. Alterations in serum thrombospondin in patients with amyotrophic lateral sclerosis. J. Neurol. Sci. 1994;127:207&#x2013;213. doi: 10.1016/0022-510X(94)90074-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0022-510X(94)90074-4</ArticleId><ArticleId IdType="pubmed">7535841</ArticleId></ArticleIdList></Reference><Reference><Citation>Talib L.L., Joaquim H.P., Forlenza O.V. Platelet biomarkers in Alzheimer&#x2019;s disease. World J. Psychiatry. 2012;2:95&#x2013;101. doi: 10.5498/wjp.v2.i6.95.</Citation><ArticleIdList><ArticleId IdType="doi">10.5498/wjp.v2.i6.95</ArticleId><ArticleId IdType="pmc">PMC3782189</ArticleId><ArticleId IdType="pubmed">24175175</ArticleId></ArticleIdList></Reference><Reference><Citation>Ponomarev E.D. Fresh evidence for platelets as neuronal and innate immune cells: Their role in the activation, differentiation, and deactivation of Th1, Th17, and Tregs during tissue inflammation. Front. Immunol. 2018;9:406. doi: 10.3389/fimmu.2018.00406.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.00406</ArticleId><ArticleId IdType="pmc">PMC5863511</ArticleId><ArticleId IdType="pubmed">29599771</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretini V., Koenen M.H., Kaestner L., Fens M.H.A.M., Schiffelers R.M., Bartels M., Van Wijk R. Red Blood Cells: Chasing Interactions. Front. Physiol. 2019;10:945. doi: 10.3389/fphys.2019.00945.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2019.00945</ArticleId><ArticleId IdType="pmc">PMC6684843</ArticleId><ArticleId IdType="pubmed">31417415</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodman S.R., Shiffer K. The spectrin membrane skeleton of normal and abnormal human erythrocytes: A review. Am. J. Physiol. 1983;244:121&#x2013;141. doi: 10.1152/ajpcell.1983.244.3.C121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajpcell.1983.244.3.C121</ArticleId><ArticleId IdType="pubmed">6338732</ArticleId></ArticleIdList></Reference><Reference><Citation>Mankelow T.J., Satchwell T.J., Burton N.M. Refined views of multiprotein complexes in the erythrocyte membrane. Blood Cells Mol. Dis. 2012;49:1&#x2013;10. doi: 10.1016/j.bcmd.2012.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcmd.2012.03.001</ArticleId><ArticleId IdType="pmc">PMC4443426</ArticleId><ArticleId IdType="pubmed">22465511</ArticleId></ArticleIdList></Reference><Reference><Citation>Lux S.D. Anatomy of the red cell membrane skeleton: Unanswered questions. Blood. 2016;127:187&#x2013;199. doi: 10.1182/blood-2014-12-512772.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2014-12-512772</ArticleId><ArticleId IdType="pubmed">26537302</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan L., Yan R., Li W., Xu K. Super-Resolution Microscopy Reveals the Native Ultrastructure of the Erythrocyte Cytoskeleton. Cell Rep. 2018;22:1151&#x2013;1158. doi: 10.1016/j.celrep.2017.12.107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2017.12.107</ArticleId><ArticleId IdType="pubmed">29386104</ArticleId></ArticleIdList></Reference><Reference><Citation>Thangaraju K., Neerukonda S.N., Katneni U., Buehler P.W. Extracellular Vesicles from Red Blood Cells and Their Evolving Roles in Health, Coagulopathy and Therapy. Int. J. Mol. Sci. 2021;22:153. doi: 10.3390/ijms22010153.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22010153</ArticleId><ArticleId IdType="pmc">PMC7796437</ArticleId><ArticleId IdType="pubmed">33375718</ArticleId></ArticleIdList></Reference><Reference><Citation>Aoki T. A Comprehensive Review of Our Current Understanding of Red Blood Cell (RBC) Glycoproteins. Membranes. 2017;7:56. doi: 10.3390/membranes7040056.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/membranes7040056</ArticleId><ArticleId IdType="pmc">PMC5746815</ArticleId><ArticleId IdType="pubmed">28961212</ArticleId></ArticleIdList></Reference><Reference><Citation>Staricoff M.A., Tanner M.J.A. Role of band 3 and glycophorin C in the maintenance of the shape and mechanical properties of the human red blood cell. Cell. Mol. Biol. Lett. 1996;2:151&#x2013;161.</Citation></Reference><Reference><Citation>Appell K.C., Low P.S. Evaluation of structural interdependence of membrane-spanning and cytoplasmic domains of band 3. Biochemistry. 1982;21:2151&#x2013;2157. doi: 10.1021/bi00538a026.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/bi00538a026</ArticleId><ArticleId IdType="pubmed">7093237</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohandas N., Evans E. Mechanical properties of the red cell membrane in relation to molecular structure and genetic defects. Annu. Rev. Biophys. Biomol. Struct. 1994;23:787&#x2013;818. doi: 10.1146/annurev.bb.23.060194.004035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.bb.23.060194.004035</ArticleId><ArticleId IdType="pubmed">7919799</ArticleId></ArticleIdList></Reference><Reference><Citation>Willekens F.L., Bosch F.H., Roerdinkholder-Stoelwinder B., Groenen-Dopp Y.A.M., Werre J.M. Quantification of loss of haemoglobin components from the circulating red blood cell in vivo. Eur. J. Haematol. 1997;58:246&#x2013;250. doi: 10.1111/j.1600-0609.1997.tb01662.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0609.1997.tb01662.x</ArticleId><ArticleId IdType="pubmed">9186535</ArticleId></ArticleIdList></Reference><Reference><Citation>Franco R.S., Puchulu-Campanella M.E., Barber L.A., Palascak M.B., Joiner C.H., Low P.S., Cohen R.M. Changes in the properties of normal human red blood cells during in vivo aging. Am. J. Hematol. 2012;88:44&#x2013;51. doi: 10.1002/ajh.23344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.23344</ArticleId><ArticleId IdType="pmc">PMC4067949</ArticleId><ArticleId IdType="pubmed">23115087</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford J. Red blood cell morphology. Int. Soc. Lab. Hematol. 2013;35:351&#x2013;357. doi: 10.1111/ijlh.12082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ijlh.12082</ArticleId><ArticleId IdType="pubmed">23480230</ArticleId></ArticleIdList></Reference><Reference><Citation>Girasole M., Dinarelli S., Boumis G. Structure and function in native and pathological erythrocytes: A quantitative view from the nanoscale. Micron. 2012;43:1273&#x2013;1286. doi: 10.1016/j.micron.2012.03.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micron.2012.03.019</ArticleId><ArticleId IdType="pubmed">22537716</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarelli S., Krumova S., Todinova S., Taneva S.G., Lenzi E., Mussi V., Longo G., Girasole M. Insight into the Morphological Pattern Observed Along the Erythrocytes&#x2019; Aging: Coupling Quantitative AFM Data to microcalorimetry and Raman spectroscopy. J. Mol. Recognit. 2018;31:e2732. doi: 10.1002/jmr.2732.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmr.2732</ArticleId><ArticleId IdType="pubmed">29876977</ArticleId></ArticleIdList></Reference><Reference><Citation>Geekiyanage N.M., Sauret E., Saha S.C., Flower R.L., Gu Y.T. Deformation behaviour of stomatocyte, discocyte and echinocyte red blood cell morphologies during optical tweezers stretching. Biomech. Model. Mechanobiol. 2020;19:1827&#x2013;1843. doi: 10.1007/s10237-020-01311-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10237-020-01311-w</ArticleId><ArticleId IdType="pubmed">32100179</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing X., Jin H., Lu Y., Wang Q., Pan Y., Cai J., Wang H. Detection of erythrocytes in patient with elliptocytosis complicating ITP using atomic force microscopy. Micron. 2011;42:42&#x2013;46. doi: 10.1016/j.micron.2010.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micron.2010.08.004</ArticleId><ArticleId IdType="pubmed">20851616</ArticleId></ArticleIdList></Reference><Reference><Citation>Danek A., Walker R.H. Neuroacanthocytosis. Curr. Opin. Neurol. 2005;18:386&#x2013;392. doi: 10.1097/01.wco.0000173464.01888.e9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wco.0000173464.01888.e9</ArticleId><ArticleId IdType="pubmed">16003113</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen D.B., Ly T.B.T., Bernhardt I. Microvesicles Released from Human Red Blood Cells: Properties and Potential Application. In: Wang J., editor. Novel Implications of Exosomes in Diagnosis and Treatment of Cancer and Infectious Diseases. InTechOpen; London, UK: 2017. pp. 137&#x2013;161.</Citation></Reference><Reference><Citation>Malka R., Delgado F.F., Manalis S.R., Higgins J.M. In vivo volume and hemoglobin dynamics of human red blood cells. PLoS Comput. Biol. 2014;10:e1003839. doi: 10.1371/journal.pcbi.1003839.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003839</ArticleId><ArticleId IdType="pmc">PMC4191880</ArticleId><ArticleId IdType="pubmed">25299941</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.H., Bu X.L., Jin W.S., Shen L.L., Wang J., Zhuang Z.Q., Zhang T., Zeng F., Yao X.Q., Zhou H.D., et al. Altered peripheral profile of blood cells in Alzheimer disease: A hospital-based case-control study. Medicine. 2017;96:e6843. doi: 10.1097/MD.0000000000006843.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MD.0000000000006843</ArticleId><ArticleId IdType="pmc">PMC5457855</ArticleId><ArticleId IdType="pubmed">28538375</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Zhou X., Chen J., Pan M., Gao H., Zhou J., Wang D., Chen Q., Zhang X., Wang Q., et al. Lower hemoglobin levels in patients with parkinson&#x2019;s disease are associated with disease severity and iron metabolism. Brain Res. 2017;1655:145&#x2013;151. doi: 10.1016/j.brainres.2016.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.11.007</ArticleId><ArticleId IdType="pubmed">27840188</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Begley J.G., Mark R.J., Furukawa K. A&#x3b2;25&#x2013;35 induces rapid lysis of red blood cells: Contrast with A&#x3b2;1&#x2013;42 and examination of underlying mechanisms. Brain Res. 1997;771:147&#x2013;153. doi: 10.1016/S0006-8993(97)00824-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0006-8993(97)00824-X</ArticleId><ArticleId IdType="pubmed">9383018</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohanty J.G., Eckley D.M., Williamson J.D., Launer L.J., Rifkind J.M. Do red blood cell-&#x3b2;-amyloid interactions alter oxygen delivery in Alzheimer&#x2019;s disease? Adv. Exp. Med. Biol. 2008;614:29&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pubmed">18290311</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson A., Lopez D., Khoo P., Kalaria R.N., Mukaetova-Ladinska E.B. Exploring Erythrocytes as Blood Biomarkers for Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2017;60:845&#x2013;857. doi: 10.3233/JAD-170363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170363</ArticleId><ArticleId IdType="pubmed">28984593</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan J., Liu J., Zhao Z., Xue R., Zhang N., Zhang P., Zhao P., Zheng F., Sun X. The peripheral blood of A&#x3b2; binding RBC as a biomarker for diagnosis of Alzheimer&#x2019;s disease. Age Ageing. 2015;44:458&#x2013;464. doi: 10.1093/ageing/afv009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afv009</ArticleId><ArticleId IdType="pubmed">25673873</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniele S., Frosini D., Pietrobono D., Petrozzi L., Lo Gerfo A., Baldacci F., Fusi J., Giacomelli C., Siciliano G., Trincavelli M.L., et al. &#x3b1;-Synuclein Heterocomplexes with &#x3b2;-Amyloid Are Increased in Red Blood Cells of Parkinson&#x2019;s Disease Patients and Correlate with Disease Severity. Front. Mol. Neurosci. 2018;11:53. doi: 10.3389/fnmol.2018.00053.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00053</ArticleId><ArticleId IdType="pmc">PMC5827358</ArticleId><ArticleId IdType="pubmed">29520218</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X., Yu S., Li F., Feng T. Detection of &#x3b1;-synuclein oligomers in red blood cells as a potential biomarker of Parkinson&#x2019;s disease. Neurosci. Lett. 2015;599:115&#x2013;119. doi: 10.1016/j.neulet.2015.05.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2015.05.030</ArticleId><ArticleId IdType="pubmed">25998655</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian C., Liu G., Gao L., Soltys D., Pan C., Stewart T., Shi M., Xie Z., Liu N., Feng T., et al. Erythrocytic &#x3b1;-Synuclein as a potential biomarker for Parkinson&#x2019;s disease. Transl. Neurodegener. 2019;8:15. doi: 10.1186/s40035-019-0155-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-019-0155-y</ArticleId><ArticleId IdType="pmc">PMC6521422</ArticleId><ArticleId IdType="pubmed">31123587</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsumoto J., Stewart T., Sheng L., Li N., Bullock K., Song N., Shi M., Banks W.A., Zhang J. Transmission of &#x3b1;-synuclein-containing erythrocyte-derived extracellular vesicles across the blood-brain barrier via adsorptive mediated transcytosis: Another mechanism for initiation and progression of Parkinson&#x2019;s disease? Acta Neuropathol. Commun. 2017;5:71. doi: 10.1186/s40478-017-0470-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-017-0470-4</ArticleId><ArticleId IdType="pmc">PMC5598000</ArticleId><ArticleId IdType="pubmed">28903781</ArticleId></ArticleIdList></Reference><Reference><Citation>Jellinger K.A. The enigma of mixed dementia. Alzheimer&#x2019;s Dement. 2007;3:40&#x2013;53. doi: 10.1016/j.jalz.2006.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2006.09.002</ArticleId><ArticleId IdType="pubmed">19595916</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima C., Pinto S., Napoleao P., Pronto-Laborinho A.C., Barrob M.A., Freitas T., de Carvalhob M., Saldanha C. Identification of erythrocyte biomarkers in amyotrophic lateral sclerosis. Clin. Hemorheol. Microcirc. 2016;63:423&#x2013;437. doi: 10.3233/CH-162066.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-162066</ArticleId><ArticleId IdType="pubmed">27258202</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsteens D., Gaub H., Newton R., Pfreundschuh M.G., Christoph M., Daniel J. Atomic force microscopy-based characterization and design of biointerfaces. Nat. Rev. Mater. 2017;2:17008. doi: 10.1038/natrevmats.2017.8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/natrevmats.2017.8</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan G., He Y., Mei L. Atomic force microscopy: A nanobiotechnology for cellular research. Nano Trans. Med. 2022;1:e9130004. doi: 10.26599/NTM.2022.9130004.</Citation><ArticleIdList><ArticleId IdType="doi">10.26599/NTM.2022.9130004</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeow N., Tabor R.F., Garnier G. Atomic force microscopy: From red blood cells to immunohaematology. Adv. Colloid Interface Sci. 2017;249:149&#x2013;162. doi: 10.1016/j.cis.2017.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cis.2017.05.011</ArticleId><ArticleId IdType="pubmed">28515013</ArticleId></ArticleIdList></Reference><Reference><Citation>Dufr&#xea;ne Y., Ando T., Garcia R., Alsteens D., Martinez-Martin D., Engel A., Gerber C., M&#xfc;ller D.J. Imaging modes of atomic force microscopy for application in molecular and cell biology. Nat. Nanotechnol. 2017;12:295&#x2013;307. doi: 10.1038/nnano.2017.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nnano.2017.45</ArticleId><ArticleId IdType="pubmed">28383040</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Arribas A.B., Go&#xf1;i F.M., Alonso A. Lipid Self-Assemblies under the Atomic Force Microscope. Int. J. Mol. Sci. 2021;22:10085. doi: 10.3390/ijms221810085.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms221810085</ArticleId><ArticleId IdType="pmc">PMC8467407</ArticleId><ArticleId IdType="pubmed">34576248</ArticleId></ArticleIdList></Reference><Reference><Citation>Trindade G.S., Vilela J.M., Ferreira J.M., Aguiar P.H., Leite J.A., Guedes M.I., Lobato Z.I., Madureira M.C., da Silva M.I., da Fonseca F.G., et al. Use of atomic force microscopy as a diagnostic tool to identify orthopoxvirus. J. Virol. Methods. 2007;141:198&#x2013;204. doi: 10.1016/j.jviromet.2006.12.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2006.12.006</ArticleId><ArticleId IdType="pubmed">17239966</ArticleId></ArticleIdList></Reference><Reference><Citation>Viljoen A., Matheli&#xe9;-Guinlet M., Ray A., Strohmeyer N., Oh Y.L., Hinterdorfer P., M&#xfc;ller D.J., Alsteens D., Dufr&#xea;ne Y.F. Force spectroscopy of single cells using atomic force microscopy. Nat. Rev. Methods Primers. 2021;1:63. doi: 10.1038/s43586-021-00062-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s43586-021-00062-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Krieg M., Fl&#xe4;schner G., Alsteens D., Gaub B.M., Roos W.H., Wuite G.J.L., Gaub H.E., Gerber C., Dufr&#xea;ne Y.F., M&#xfc;ller D.J. Atomic force microscopy-based mechanobiology. Nat. Rev. Phys. 2019;1:41&#x2013;57. doi: 10.1038/s42254-018-0001-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s42254-018-0001-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Iyer S., Gaikwad R.M., Subba-Rao V., Woodworth C.D., Sokolov I. Atomic force microscopy detects differences in the surface brush of normal and cancerous cells. Nat. Nanotechnol. 2009;4:389&#x2013;393. doi: 10.1038/nnano.2009.77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nnano.2009.77</ArticleId><ArticleId IdType="pmc">PMC3079421</ArticleId><ArticleId IdType="pubmed">19498402</ArticleId></ArticleIdList></Reference><Reference><Citation>Cross S.E., Jin Y.S., Rao J., Gimzewski J.K. Nanomechanical analysis of cells from cancer patients. Nat. Nanotechnol. 2007;2:780&#x2013;783. doi: 10.1038/nnano.2007.388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nnano.2007.388</ArticleId><ArticleId IdType="pubmed">18654431</ArticleId></ArticleIdList></Reference><Reference><Citation>Plodinec M., Loparic M., Monnier C.A., Obermann E.C., Zanetti-Dallenbach R., Oertle P., Hyotyla J.T., Aebi U., Bentires-Alj M., Lim R.Y., et al. The nanomechanical signature of breast cancer. Nat. Nanotechnol. 2012;7:757&#x2013;765. doi: 10.1038/nnano.2012.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nnano.2012.167</ArticleId><ArticleId IdType="pubmed">23085644</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokolov I., Dokukin M.E., Kalaparthi V., Miljkovic M., Wang A., Seigne J.D., Grivas P., Demidenko E. Noninvasive diagnostic imaging using machine-learning analysis of nanoresolution images of cell surfaces: Detection of bladder cancer. Proc. Natl. Acad. Sci. USA. 2018;115:12920&#x2013;12925. doi: 10.1073/pnas.1816459115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1816459115</ArticleId><ArticleId IdType="pmc">PMC6304950</ArticleId><ArticleId IdType="pubmed">30509988</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt H.J., Wolff E.K., Gould S.A., Dixon Northern B., Peterson C.M., Hansma P.K. Imaging cells with the atomic force microscope. J. Struct. Biol. 1990;105:54&#x2013;61. doi: 10.1016/1047-8477(90)90098-W.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/1047-8477(90)90098-W</ArticleId><ArticleId IdType="pubmed">2100150</ArticleId></ArticleIdList></Reference><Reference><Citation>Gould S.A.C., Drake B., Prater C.B., Weisenhorn A.L., Manne S., Hansma H.G., Hansma P.K., Masse J., Longmire M., Elings V., et al. From atoms to integrated-circuit chips, blood cells and bacteria with the atomic force microscope. J. Vac. Sci. Technol. 1990;8:369&#x2013;375. doi: 10.1116/1.576398.</Citation><ArticleIdList><ArticleId IdType="doi">10.1116/1.576398</ArticleId></ArticleIdList></Reference><Reference><Citation>Zach&#xe9;e P., Snauwaert J., Vandenberghe P., Hellemans L., Boogaerts M. Imaging red blood cells with the atomic force microscope. Br. J. Haematol. 1996;95:472&#x2013;481. doi: 10.1111/j.1365-2141.1996.tb08991.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1365-2141.1996.tb08991.x</ArticleId><ArticleId IdType="pubmed">8943887</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang W., Wang S., Wang C., Xie J., Chen X., Xu Y., Mao P. Detection of human erythrocytes influenced by iron deficiency anemia and thalassemia using atomic force microscopy. Micron. 2012;43:1287&#x2013;1292. doi: 10.1016/j.micron.2011.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micron.2011.10.018</ArticleId><ArticleId IdType="pubmed">22154342</ArticleId></ArticleIdList></Reference><Reference><Citation>Strijkova-Kenderova V., Todinova S., Andreeva T., Bogdanova D., Langari A., Danailova A., Krumova S., Zlatareva E., Kalaydzhiev N., Milanov I., et al. Morphometry and Stiffness of Red Blood Cells&#x2014;Signatures of Neurodegenerative Diseases and Aging. Int. J. Mol. Sci. 2022;23:227. doi: 10.3390/ijms23010227.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23010227</ArticleId><ArticleId IdType="pmc">PMC8745649</ArticleId><ArticleId IdType="pubmed">35008653</ArticleId></ArticleIdList></Reference><Reference><Citation>Girasole M., Pompeo G., Cricenti A., Congiu-Castellano A., Andreola F., Serafino A., Frazer B.H., Boumis G., Amiconi G. Roughness of the plasma membrane as an independent morphological parameter to study RBCs: A quantitative atomic force microscopy investigation. Biochim. Biophys. Acta. 2007;1768:1268&#x2013;1276. doi: 10.1016/j.bbamem.2007.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2007.01.014</ArticleId><ArticleId IdType="pubmed">17320813</ArticleId></ArticleIdList></Reference><Reference><Citation>Girasole M., Dinarelli S., Boumis G. Structural, morphological and nanomechanical characterisation of intermediate states in the ageing of erythrocytes. J. Mol. Recognit. 2012;25:285&#x2013;291. doi: 10.1002/jmr.2170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmr.2170</ArticleId><ArticleId IdType="pubmed">22528190</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamruzzahan A.S.M., Kienberger F., Stroh C.M., Berg J., Huss R., Ebner A., Zhu R., Rank C., Gruber H.J., Hinterdorfer P. Imaging morphological details and pathological differences of red blood cells using tapping-mode AFM. Biol. Chem. 2004;385:955&#x2013;960. doi: 10.1515/BC.2004.124.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/BC.2004.124</ArticleId><ArticleId IdType="pubmed">15551870</ArticleId></ArticleIdList></Reference><Reference><Citation>Duli&#x144;ska I., Targosz M., Strojny W., Lekka M., Czuba P., Balwierz W., Szymo&#x144;ski M. Stiffness of normal and pathological erythrocytes studied by means of atomic force microscopy. J. Biochem. Biophys. Methods. 2006;66:1&#x2013;11. doi: 10.1016/j.jbbm.2005.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbbm.2005.11.003</ArticleId><ArticleId IdType="pubmed">16443279</ArticleId></ArticleIdList></Reference><Reference><Citation>Ciasca G., Papi M., Di Claudio S., Chiarpotto M., Palmieri V., Maulucci G., Nocca G., Rossi C., De Spirito M. Mapping viscoelastic properties of healthy and pathological red blood cells at the nanoscale level. Nanoscale. 2015;7:17030&#x2013;17037. doi: 10.1039/C5NR03145A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C5NR03145A</ArticleId><ArticleId IdType="pubmed">26415744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Zhang W., Wang S., Wang C., Xie J., Chen X., Xu Y., Mao P. Detection of erythrocytes in patients with multiple myeloma using atomic force microscopy. Scanning. 2012;34:295&#x2013;301. doi: 10.1002/sca.21008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/sca.21008</ArticleId><ArticleId IdType="pubmed">22311545</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li J. Detection of erythrocytes in patients with Waldenstr&#xf6;m macroglobulinemia using atomic force microscopy. Acta Biochim. Biophys. Sin. 2014;46:420&#x2013;425. doi: 10.1093/abbs/gmu015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/abbs/gmu015</ArticleId><ArticleId IdType="pubmed">24675428</ArticleId></ArticleIdList></Reference><Reference><Citation>Cluitmans J.C.A., Tomelleri C., Yapici Z., Dinkla S., Bovee-Geurts P., Chokkalingam V., De Franceschi L., Brock R., Bosman G.J. Abnormal Red Cell Structure and Function in Neuroacanthocytosis. PLoS ONE. 2015;10:e0125580. doi: 10.1371/journal.pone.0125580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0125580</ArticleId><ArticleId IdType="pmc">PMC4416783</ArticleId><ArticleId IdType="pubmed">25933379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sot J., Garc&#xed;a-Arribas A.B., Abad B., Arranz S., Portune K., Andrade F., Mart&#xed;n-Nieto A., Velasco O., Arana E., Tueros I., et al. Erythrocyte Membrane Nanomechanical Rigidity Is Decreased in Obese Patients. Int. J. Mol. Sci. 2022;23:1920. doi: 10.3390/ijms23031920.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031920</ArticleId><ArticleId IdType="pmc">PMC8836476</ArticleId><ArticleId IdType="pubmed">35163842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kozlova E., Sergunova V., Sherstyukova E., Gudkova O., Kozlov A., Inozemtsev V., Lyapunova S., Chernysh A. Topological Relationships Cytoskeleton-Membrane Nanosurface-Morphology as a Basic Mechanism of Total Disorders of RBC Structures. Int. J. Mol. Sci. 2022;23:2045. doi: 10.3390/ijms23042045.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23042045</ArticleId><ArticleId IdType="pmc">PMC8876224</ArticleId><ArticleId IdType="pubmed">35216154</ArticleId></ArticleIdList></Reference><Reference><Citation>Korniluk A., Koper-Lenkiewicz O.M., Kami&#x144;ska J., Kemona H., Dymicka-Piekarska V. Mean Platelet Volume (MPV): New Perspectives for an Old Marker in the Course and Prognosis of Inflammatory Conditions. Mediat. Inflamm. 2019;2019:9213074. doi: 10.1155/2019/9213074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/9213074</ArticleId><ArticleId IdType="pmc">PMC6501263</ArticleId><ArticleId IdType="pubmed">31148950</ArticleId></ArticleIdList></Reference><Reference><Citation>Braneh&#xf6;g I., Kutti J., Ridell B., Swolin B., Weinfeld A. The relation of thrombokinetics to bone marrow megakaryocytes in idiopathic thrombocytopenic purpura (ITP) Blood. 1975;45:551&#x2013;562. doi: 10.1182/blood.V45.4.551.551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.V45.4.551.551</ArticleId><ArticleId IdType="pubmed">1167796</ArticleId></ArticleIdList></Reference><Reference><Citation>Chu S.G., Becker R.C., Berger P.B., Bhatt D.L., Eikelboom J.W., Konkle B., Mohler E.R., Reilly M.P., Berger J.S. Mean platelet volume as a predictor of cardiovascular risk: A systematic review and meta-analysis. J. Thromb. Haemost. 2010;8:148&#x2013;156. doi: 10.1111/j.1538-7836.2009.03584.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1538-7836.2009.03584.x</ArticleId><ArticleId IdType="pmc">PMC3755496</ArticleId><ArticleId IdType="pubmed">19691485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava M., Das T.K., Behari M., Pati U., Vivekanandhan S. Ultrastructural Variations in Platelets and Platelet Mitochondria: A Novel Feature in Amyotrophic Lateral Sclerosis. Ultrastruct. Pathol. 2011;35:52&#x2013;59. doi: 10.3109/01913123.2010.541985.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/01913123.2010.541985</ArticleId><ArticleId IdType="pubmed">21299344</ArticleId></ArticleIdList></Reference><Reference><Citation>Cole M.G., Prchal J.F. Low serum vitamin B12 in Alzheimer-type dementia. Age Ageing. 1984;13:101&#x2013;105. doi: 10.1093/ageing/13.2.101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/13.2.101</ArticleId><ArticleId IdType="pubmed">6731164</ArticleId></ArticleIdList></Reference><Reference><Citation>McCaddon A. Vitamin B12 in neurology and ageing; Clinical and genetic aspects. Biochimie. 2013;95:1066&#x2013;1076. doi: 10.1016/j.biochi.2012.11.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biochi.2012.11.017</ArticleId><ArticleId IdType="pubmed">23228515</ArticleId></ArticleIdList></Reference><Reference><Citation>Najim al-Din A.S., Khojali M., Habbosh H., Farah S., Idris A.R., al-Muhtasib F. Macrocytosis in multiple sclerosis. A study in 82 de novo Arab patients. J. Neurol. Neurosurg. Psychiatry. 1991;54:415&#x2013;416. doi: 10.1136/jnnp.54.5.415.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.54.5.415</ArticleId><ArticleId IdType="pmc">PMC488540</ArticleId><ArticleId IdType="pubmed">1865203</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandaru S.S., Killeen R.B., Gupta V.  StatPearls [Internet] StatPearls Publishing; Treasure Island, FL, USA: 2023.  [(accessed on 10 August 2023)]. Poikilocytosis. Available online:  https://www.ncbi.nlm.nih.gov/books/NBK562141/</Citation></Reference><Reference><Citation>Kozlova E., Sherstyukova E., Sergunova V., Grechko A., Kuzovlev A., Lyapunova S., Inozemtsev V., Kozlov A., Chernysh A. Atomic Force Microscopy and High-Resolution Spectrophotometry for Study of Anoxemia and Normoxemia in Model Experiment In Vitro. Int. J. Mol. Sci. 2023;24:11043. doi: 10.3390/ijms241311043.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms241311043</ArticleId><ArticleId IdType="pmc">PMC10341442</ArticleId><ArticleId IdType="pubmed">37446221</ArticleId></ArticleIdList></Reference><Reference><Citation>Bester J., Buys A.V., Lipinski B., Kell D.B., Pretorius E. High ferritin levels have major effects on the morphology of erythrocytes in Alzheimer&#x2019;s disease. Front. Aging Neurosci. 2013;5:88. doi: 10.3389/fnagi.2013.00088.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2013.00088</ArticleId><ArticleId IdType="pmc">PMC3853801</ArticleId><ArticleId IdType="pubmed">24367334</ArticleId></ArticleIdList></Reference><Reference><Citation>Pretorius E., Swanepoel A.C., Buys A.V., Vermeulen N., Duim W., Kell D.B. Eryptosis as a marker of Parkinson&#x2019;s disease. Aging. 2014;6:788&#x2013;819. doi: 10.18632/aging.100695.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.100695</ArticleId><ArticleId IdType="pmc">PMC4247384</ArticleId><ArticleId IdType="pubmed">25411230</ArticleId></ArticleIdList></Reference><Reference><Citation>Todinova S., Krumova S., Bogdanova D., Danailova A., Zlatareva E., Kalaydzhiev N., Langari A., Milanov I., Taneva S.G. Red Blood Cells&#x2019; Thermodynamic Behavior in Neurodegenerative Pathologies and Aging. Biomolecules. 2021;11:1500. doi: 10.3390/biom11101500.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom11101500</ArticleId><ArticleId IdType="pmc">PMC8534019</ArticleId><ArticleId IdType="pubmed">34680133</ArticleId></ArticleIdList></Reference><Reference><Citation>Strijkova V., Todinova S., Andreeva T., Langari A., Bogdanova D., Zlatareva E., Kalaydzhiev N., Milanov I., Taneva S.G. Platelets&#x2019; Nanomechanics and Morphology in Neurodegenerative Pathologies. Biomedicines. 2022;10:2239. doi: 10.3390/biomedicines10092239.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines10092239</ArticleId><ArticleId IdType="pmc">PMC9496241</ArticleId><ArticleId IdType="pubmed">36140340</ArticleId></ArticleIdList></Reference><Reference><Citation>Li A., Chen J., Liang Z.H., Cai J., Cai H.H., Chen M. Comparison of ultrastructural and nanomechanical signature of platelets from acute myocardial infarction and platelet activation. Biochem. Biophys. Res. Commun. 2017;486:245&#x2013;251. doi: 10.1016/j.bbrc.2017.03.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2017.03.009</ArticleId><ArticleId IdType="pubmed">28274875</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Rubio D., Rodr&#xed;guez-Varela M., Mart&#xed;nez-Vieyra I., de la Mora M.B., M&#xe9;ndez-M&#xe9;ndez J.V., Dur&#xe1;n-&#xc1;lvarez J.C., Cerecedo D. Alterations to the contents of plasma membrane structural lipids are associated with structural changes and compartmentalization in platelets in hypertension. Exp. Cell Res. 2019;385:111692. doi: 10.1016/j.yexcr.2019.111692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yexcr.2019.111692</ArticleId><ArticleId IdType="pubmed">31689412</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Rooy M.J., Duim W., Ehlers R., Buys A.V., Pretorius E. Platelet hyperactivity and fibrin clot structure in transient ischemic attack individuals in the presence of metabolic syndrome: A microscopy and thromboelastography study. Cardiovasc. Diabetol. 2015;14:86. doi: 10.1186/s12933-015-0249-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12933-015-0249-5</ArticleId><ArticleId IdType="pmc">PMC4542104</ArticleId><ArticleId IdType="pubmed">26140921</ArticleId></ArticleIdList></Reference><Reference><Citation>Andreeva T., Komsa-Penkova R., Langari A., Krumova S., Golemanov G., Georgieva G.B., Taneva S.G., Giosheva I., Mihaylova N., Tchorbanov A., et al. Morphometric and Nanomechanical Features of Platelets from Women with Early Pregnancy Loss Provide New Evidence of the Impact of Inherited Thrombophilia. Int. J. Mol. Sci. 2021;22:7778. doi: 10.3390/ijms22157778.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157778</ArticleId><ArticleId IdType="pmc">PMC8346153</ArticleId><ArticleId IdType="pubmed">34360543</ArticleId></ArticleIdList></Reference><Reference><Citation>Dinarelli S., Girasole M., Misiti F. Amyloid &#x3b2; peptide affects erythrocyte morphology: Role of intracellular signaling pathways. Clin. Hemorheol. Microcirc. 2019;71:437&#x2013;449. doi: 10.3233/CH-199007.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/CH-199007</ArticleId><ArticleId IdType="pubmed">31156152</ArticleId></ArticleIdList></Reference><Reference><Citation>Carelli-Alinovi C., Dinarelli S., Sampaolese B., Misiti F., Girasole M. Morphological changes induced in erythrocyte by amyloid beta peptide and glucose depletion: A combined atomic force microscopy and biochemical study. Biochim. Biophys. Acta (BBA) Biomembr. 2019;1861:236&#x2013;244. doi: 10.1016/j.bbamem.2018.07.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbamem.2018.07.009</ArticleId><ArticleId IdType="pubmed">30040926</ArticleId></ArticleIdList></Reference><Reference><Citation>Kosenko E.A., Tikhonova L.A., Montoliu C., Barreto G.E., Aliev G., Kaminsky Y.G. Metabolic Abnormalities of Erythrocytes as a Risk Factor for Alzheimer&#x2019;s Disease. Front. Neurosci. 2018;11:728. doi: 10.3389/fnins.2017.00728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2017.00728</ArticleId><ArticleId IdType="pmc">PMC5760569</ArticleId><ArticleId IdType="pubmed">29354027</ArticleId></ArticleIdList></Reference><Reference><Citation>Kowalewski T., Holtzman D.M. In situ atomic force microscopy study of Alzheimer&#x2019;s b-amyloid peptide on different substrates: New insights into mechanism of b-sheet formation. Proc. Natl. Acad. Sci. USA. 1999;96:3688&#x2013;3693. doi: 10.1073/pnas.96.7.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.96.7.3688</ArticleId><ArticleId IdType="pmc">PMC22355</ArticleId><ArticleId IdType="pubmed">10097098</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S., Hashemi M., Zagorski K., Lyubchenko Y.L. Interaction of A&#x3b2;42 with Membranes Triggers the Self-Assembly into Oligomers. Int. J. Mol. Sci. 2020;21:1129. doi: 10.3390/ijms21031129.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms21031129</ArticleId><ArticleId IdType="pmc">PMC7036922</ArticleId><ArticleId IdType="pubmed">32046252</ArticleId></ArticleIdList></Reference><Reference><Citation>Feuillie C., Lambert E., Ewald M., Azouz M., Henry S., Marsaudon S., Cullin C., Lecomte S., Molinari M. High Speed AFM and NanoInfrared Spectroscopy Investigation of A&#x3b2;1-42 Peptide Variants and Their Interaction With POPC/SM/Chol/GM1 Model Membranes. Front. Mol. Biosci. 2020;7:571696. doi: 10.3389/fmolb.2020.571696.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2020.571696</ArticleId><ArticleId IdType="pmc">PMC7510551</ArticleId><ArticleId IdType="pubmed">33033718</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe-Nakayama T., Ono K., Itami M., Takahashi R., Teplow D.B., Yamada M. High-speed atomic force microscopy reveals structural dynamics of amyloid &#x3b2;1-42 aggregates. Proc. Natl. Acad. Sci. USA. 2016;113:5835&#x2013;5840. doi: 10.1073/pnas.1524807113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1524807113</ArticleId><ArticleId IdType="pmc">PMC4889376</ArticleId><ArticleId IdType="pubmed">27162352</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee S., Sun Z., Hayden E.Y., Teplow D.B., Lyubchenko Y.L. Nanoscale Dynamics of Amyloid &#x3b2;-42 Oligomers As Revealed by High-Speed Atomic Force Microscopy. ACS Nano. 2017;11:12202&#x2013;12209. doi: 10.1021/acsnano.7b05434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.7b05434</ArticleId><ArticleId IdType="pmc">PMC5752618</ArticleId><ArticleId IdType="pubmed">29165985</ArticleId></ArticleIdList></Reference><Reference><Citation>Tinker-Mill C., Mayes J., Allsop D., Kolosov O.V. Ultrasonic force microscopy for nanomechanical characterization of early and late-stage amyloid-&#x3b2; peptide aggregation. Sci. Rep. 2014;4:4004. doi: 10.1038/srep04004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep04004</ArticleId><ArticleId IdType="pmc">PMC3915309</ArticleId><ArticleId IdType="pubmed">24500006</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri F.S., Benedetti F., Knowles T.P.J., Lashuel H.A., Sekatskii S., Dietler G. Identification and nanomechanical characterization of the fundamental single-strand protofilaments of amyloid &#x3b1;-synuclein fibrils. Proc. Natl. Acad. Sci. USA. 2018;115:7230&#x2013;7235. doi: 10.1073/pnas.1721220115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1721220115</ArticleId><ArticleId IdType="pmc">PMC6048494</ArticleId><ArticleId IdType="pubmed">29941606</ArticleId></ArticleIdList></Reference><Reference><Citation>Knowles T.P.J., Vendruscolo M., Dobson C.M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell Biol. 2014;15:384&#x2013;396. doi: 10.1038/nrm3810.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrm3810</ArticleId><ArticleId IdType="pubmed">24854788</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri F.S., Flagmeier P., Kumita J.R., Meisl G., Chirgadze D.Y., Bongiovanni M.N., Knowles T.P.J., Dobson C.M. The Influence of Pathogenic Mutations in &#x3b1;-Synuclein on Biophysical and Structural Characteristics of Amyloid Fibrils. ACS Nano. 2020;14:5213&#x2013;5222. doi: 10.1021/acsnano.9b09676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.9b09676</ArticleId><ArticleId IdType="pubmed">32159944</ArticleId></ArticleIdList></Reference><Reference><Citation>Camino J.D., Gracia P., Chen S.W., Sot J., de la Arada I., Sebasti&#xe1;n V., Arrondo J.L.R., Go&#xf1;i F.M., Dobson C.M., Cremades N. The extent of protein hydration dictates the preference for heterogeneous or homogeneous nucleation generating either parallel or antiparallel &#x3b2;-sheet &#x3b1;-synuclein aggregates. Chem. Sci. 2020;11:11902&#x2013;11914. doi: 10.1039/D0SC05297C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D0SC05297C</ArticleId><ArticleId IdType="pmc">PMC7816767</ArticleId><ArticleId IdType="pubmed">33520152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruggeri F.S., Adamcik J., Jeong J.S., Lashuel H.A., Mezzenga R., Dietler G. Influence of the &#x3b2;-sheet content on the mechanical properties of aggregates during amyloid fibrillization. Angew. Chem.-Int. Ed. 2015;54:2462&#x2013;2466. doi: 10.1002/anie.201409050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/anie.201409050</ArticleId><ArticleId IdType="pubmed">25588987</ArticleId></ArticleIdList></Reference><Reference><Citation>Goedert M. Alpha-synuclein and neurodegenerative diseases. Nat. Rev. Neurosci. 2001;2:492&#x2013;501. doi: 10.1038/35081564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35081564</ArticleId><ArticleId IdType="pubmed">11433374</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe H., Uchihashi T., Kobashi T., Shibata M., Nishiyama J., Yasuda R., Ando T. Wide-area scanner for high-speed atomic force microscopy. Rev. Sci. Instrum. 2013;84:053702. doi: 10.1063/1.4803449.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.4803449</ArticleId><ArticleId IdType="pubmed">23742553</ArticleId></ArticleIdList></Reference><Reference><Citation>Suzuki Y., Sakai N., Yoshida A., Yoshitsugu U., Akira Y., Yuka I., Shuichi I., Koichi K., Kunio T. High-speed atomic force microscopy combined with inverted optical microscopy for studying cellular events. Sci. Rep. 2013;3:2131. doi: 10.1038/srep02131.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep02131</ArticleId><ArticleId IdType="pmc">PMC3701170</ArticleId><ArticleId IdType="pubmed">23823461</ArticleId></ArticleIdList></Reference><Reference><Citation>Marchesi A., Umeda K., Komekawa T., Matsubara T., Holger Flechsig H., Ando T., Watanabe S., Kodera N., Franz C.M. An ultra-wide scanner for large-area high-speed atomic force microscopy with megapixel resolution. Sci. Rep. 2021;11:13003. doi: 10.1038/s41598-021-92365-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-92365-y</ArticleId><ArticleId IdType="pmc">PMC8217563</ArticleId><ArticleId IdType="pubmed">34155261</ArticleId></ArticleIdList></Reference><Reference><Citation>Dazzi A., Prater C.B., Hu Q., Chase D.B., Rabolt J.F., Marcott C. AFM-IR: Combining atomic force microscopy and infrared spectroscopy for nanoscale chemical characterization. Appl. Spectrosc. 2012;66:1365&#x2013;1384. doi: 10.1366/12-06804.</Citation><ArticleIdList><ArticleId IdType="doi">10.1366/12-06804</ArticleId><ArticleId IdType="pubmed">23231899</ArticleId></ArticleIdList></Reference><Reference><Citation>Dazzi A., Prater C.B. AFM-IR: Technology and applications in nanoscale infrared spectroscopy and chemical imaging. Chem. Rev. 2017;117:5146&#x2013;5173. doi: 10.1021/acs.chemrev.6b00448.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.chemrev.6b00448</ArticleId><ArticleId IdType="pubmed">27958707</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller E.A., Pollard B., Raschke M.B. Infrared chemical nano-imaging: Accessing structure, coupling, and dynamics on molecular length scales. J. Phys. Chem. Lett. 2015;6:1275&#x2013;1284. doi: 10.1021/acs.jpclett.5b00108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jpclett.5b00108</ArticleId><ArticleId IdType="pubmed">26262987</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldsbury C., Green J. Time-lapse atomic force microscopy in the characterization of amyloid-like fibril assembly and oligomeric intermediates. Methods Mol. Biol. 2005;299:103&#x2013;128.</Citation><ArticleIdList><ArticleId IdType="pubmed">15980598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonhommeau S., Lecomte S. Tip-Enhanced Raman Spectroscopy: A Tool for Nanoscale Chemical and Structural Characterization of Biomolecules. ChemPhysChem. 2018;9:8&#x2013;18. doi: 10.1002/cphc.201701067.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cphc.201701067</ArticleId><ArticleId IdType="pubmed">29106771</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao F., Zenobi R. Tip-enhanced Raman spectroscopy: Principles, practice, and applications to nanospectroscopic imaging of 2D materials. Anal. Bioanal. Chem. 2019;411:37&#x2013;61. doi: 10.1007/s00216-018-1392-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00216-018-1392-0</ArticleId><ArticleId IdType="pubmed">30306237</ArticleId></ArticleIdList></Reference><Reference><Citation>Buys A.V., Van Rooy M.-J., Soma P., Van Papendorp D., Lipinski B., Pretorius E. Changes in red blood cell membrane structure in type 2 diabetes: A scanning electron and atomic force microscopy study. Cardiovasc. Diabetol. 2013;12:25. doi: 10.1186/1475-2840-12-25.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2840-12-25</ArticleId><ArticleId IdType="pmc">PMC3599682</ArticleId><ArticleId IdType="pubmed">23356738</ArticleId></ArticleIdList></Reference><Reference><Citation>Alummoottil S., van Rooy M.J., Bester J., Grobbelaar C., Phulukdaree A. Scanning Electron and Atomic Force Microscopic Analysis of Erythrocytes in a Cohort of Atopic Asthma Patients&#x2014;A Pilot Study. Hemato. 2023;4:90&#x2013;99. doi: 10.3390/hemato4010009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/hemato4010009</ArticleId></ArticleIdList></Reference><Reference><Citation>Uchihashi T., Scheuring S. Applications of high-speed atomic force microscopy to real-time visualization of dynamic biomolecular processes, Biochim. Biophys. Acta-Gen. Subj. 2018;1862:229&#x2013;240. doi: 10.1016/j.bbagen.2017.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbagen.2017.07.010</ArticleId><ArticleId IdType="pubmed">28716648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ando T., Kodera N., Takai E., Maruyama D., Saito K., Toda A. A high-speed atomic force microscope for studying biological macromolecules. Proc. Natl. Acad. Sci. USA. 2001;98:12468&#x2013;12472. doi: 10.1073/pnas.211400898.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.211400898</ArticleId><ArticleId IdType="pmc">PMC60077</ArticleId><ArticleId IdType="pubmed">11592975</ArticleId></ArticleIdList></Reference><Reference><Citation>Milhiet P.E., Yamamoto D., Berthoumieu O., Dosset P., le Grimellec C., Verdier J.M., Marchal S., Ando T. Deciphering the structure, growth and assembly of amyloid-like fibrils using high-speed atomic force microscopy. PLoS ONE. 2010;5:e13240. doi: 10.1371/journal.pone.0013240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013240</ArticleId><ArticleId IdType="pmc">PMC2951901</ArticleId><ArticleId IdType="pubmed">20949034</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadeghian H., Herfst R., Dekker B., Winters J., Bijnagte T., Rijnbeek R. High-throughput atomic force microscopes operating in parallel. Rev. Sci. Instrum. 2017;88:033703. doi: 10.1063/1.4978285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.4978285</ArticleId><ArticleId IdType="pubmed">28372370</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia F., Youcef-Toumi K., Sattel T., Manske E., Rangelow I.W. Active Probe Atomic Force Microscopy with Quattro-Parallel Cantilever Arrays for High-Throughput Large-Scale Sample Inspection. J. Vis. Exp. 2023;196:e65210. doi: 10.3791/65210.</Citation><ArticleIdList><ArticleId IdType="doi">10.3791/65210</ArticleId><ArticleId IdType="pubmed">37395592</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsukada K., Sekizuka E., Oshio C., Minamitani H. Direct measurement of erythrocyte deformability in diabetes mellitus with a transparent microchannel capillary model and high-speed video camera system. Microvasc. Res. 2001;61:231&#x2013;239. doi: 10.1006/mvre.2001.2307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/mvre.2001.2307</ArticleId><ArticleId IdType="pubmed">11336534</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaiuolo G. Biomechanical properties of red blood cells in health and disease towards microfluidics. Biomicrofluidics. 2014;8:051501. doi: 10.1063/1.4895755.</Citation><ArticleIdList><ArticleId IdType="doi">10.1063/1.4895755</ArticleId><ArticleId IdType="pmc">PMC4189537</ArticleId><ArticleId IdType="pubmed">25332724</ArticleId></ArticleIdList></Reference><Reference><Citation>Faivre M., Renoux C., Bessaa A., Da Costa L., Joly J., Gauthier A., Connes P. Mechanical Signature of Red Blood Cells Flowing Out of a Microfluidic Constriction Is Impacted by Membrane Elasticity, Cell Surface-to-Volume Ratio and Diseases. Front. Physiol. 2020;11:576. doi: 10.3389/fphys.2020.00576.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2020.00576</ArticleId><ArticleId IdType="pmc">PMC7303906</ArticleId><ArticleId IdType="pubmed">32595519</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Nguyen J., Wai Y., Sun Y. Recent advances in microfluidic techniques for single-cell biophysical characterization. Lab Chip. 2013;13:2464&#x2013;2483. doi: 10.1039/c3lc50355k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c3lc50355k</ArticleId><ArticleId IdType="pubmed">23681312</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino V., Pinho D., Yaginuma T., Calhelha R.C., Ferreira I.C.F.R., Lima R. Extensional flow-based microfluidic device: Deformability assessment of red blood cells in contact with tumor cells. Biochip J. 2014;8:42&#x2013;47. doi: 10.1007/s13206-014-8107-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13206-014-8107-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Faustino V., Rodrigues R.O., Pinho D., Costa E., Santos-Silva A., Miranda V., Amaral J.S., Lima R. A microfluidic deformability assessment of pathological red blood cells flowing in a hyperbolic converging microchannel. Micromachines. 2019;10:645. doi: 10.3390/mi10100645.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mi10100645</ArticleId><ArticleId IdType="pmc">PMC6843121</ArticleId><ArticleId IdType="pubmed">31557932</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomaiuolo G., Guido S. Start-up shape dynamics of red blood cells in microcapillary flow. Microvasc. Res. 2011;82:35&#x2013;41. doi: 10.1016/j.mvr.2011.03.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mvr.2011.03.004</ArticleId><ArticleId IdType="pubmed">21397612</ArticleId></ArticleIdList></Reference><Reference><Citation>Braunm&#xfc;ller S., Schmid L., Sackmann E., Franke T. Hydrodynamic deformation reveals two coupled modes/time scales of red blood cell relaxation. Soft Matter. 2012;8:11240&#x2013;11248. doi: 10.1039/c2sm26513c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c2sm26513c</ArticleId></ArticleIdList></Reference><Reference><Citation>Prado G., Farutin A., Misbah C., Bureau L. Viscoelastic transient of confined red blood cells. Biophys. J. 2015;108:2126&#x2013;2136. doi: 10.1016/j.bpj.2015.03.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpj.2015.03.046</ArticleId><ArticleId IdType="pmc">PMC4423063</ArticleId><ArticleId IdType="pubmed">25954871</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaki T., Shin Y., Sivathanu V., Campisi M., Kamm R.D. In Vitro Microfluidic Models for Neurodegenerative Disorders. Adv. Healthc. Mater. 2018;7:1700489. doi: 10.1002/adhm.201700489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/adhm.201700489</ArticleId><ArticleId IdType="pubmed">28881425</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>